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CHAPTER I 
 
INTRODUCTION 
 
DNA replication 
 DNA replication is fundamental to the survival of cells and preservation of species 
throughout evolution.   Defects in duplication of the genome can lead to detrimental 
consequences even at the organism level. Mistakes in replication synthesis can introduce 
unfavorable mutations resulting in genetic instability and translating into the production of 
disabled or faulty proteins that can no longer perform their unique cellular tasks.  Mutations can 
ultimately result in genetic disorders and progress to fatal diseases such as cancer.  It is the 
accrual of multiple genetic mutations that result in massive cellular differentiation and gives rise 
to what in advance stages becomes uncontrolled tumor growth.   
 DNA replication in humans is mediated by complex multi-protein machinery.  This 
machinery is built by timely expressed proteins that assemble strategically during the early 
stages of cell cycle, recognizing the origin of replication and licensing replication for initiation at 
the start of the synthesis phase where accurate and efficient elongation and termination of 
replication take place.  At the center of the replication machinery is replication protein A (RPA), 
the major single strand DNA (ssDNA) binding protein.  RPA binds and protects ssDNA from 
degradation by endonucleases while at the same time preventing the strands form re-annealing 
and forming secondary structures that may interfere with the smooth transition of replication.  
Remarkably, when replication encounters damaged DNA the replication process is stopped and 
depending of the type of damage, specialized repair mechanisms are triggered that respond to the 
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specific type of damage.  One of the signals that accompany recognition of DNA damage is the 
hyperphosphorylation of RPA, which contributes to stalling of replication.  However, it is 
unknown what changes in RPA are induced by hyperphosphorylation, and how these signal the 
switch from replication to damage response and repair.   
 
Replication Protein A 
 RPA is the primary ssDNA binding protein in humans and other eukaryotes.  It is 
modular in composition, formed by three subunits of 70, 32 and 14 KDa, and named on the basis 
of their respective molecular weights (Figure 1).  The RPA70 subunit contains four 
oligonucleotide-oligosaccharide binding (OB fold) domains spanning residues 1-120 (RPA70N), 
181-290 (RPA70A), 300-422 (RPA70B) and 436-616 (RPA70C). The RPA32 subunit contains 
one OB fold spanning residues 46-171 (RPA32D) flanked by an unstructured N-terminal domain 
(1-45, RPA32N) and a winged helix-loop-helix C-terminal domain (200-270, RPA32C).  RPA14  
 
 
Figure 1.1.  Domain organization of RPA.  The domain composition of each of RPA subunits, 
RPA70, RPA32 and RPA14 is different.   RPA has six OB-fold domains and one HLH domain. 
 
C
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is a single OB fold domain.  Trimerization of RPA occurs through the association of RPA70C,  
RPA32D and RPA14 inter-domain interactions and it is only this heterotrimeric form of RPA 
that is active in DNA processing.  The ssDNA binding activity of RPA has been mapped to 
RPA70A, RPA70B, RPA70C and RPA32D domain, whereas protein interaction are mediated by 
RPA70N, RPA70A, RPA70B, and RPA32C domains (Figure 1). 
 OB-folds are characterized by 5-stranded antiparallel β sheets, with an α helix between 
the third and fourth strands [1] (Figure 2).  This motif folds into a closed β-barrel, which 
typically harbors a notable basic patch positioned in between loops 1-2 and 4-5 that is the 
preferred site of interaction for ssDNA and proteins.  The basicity of the basic cleft differs from 
one OB-fold to another in accord with function.  Each ssDNA interacting domain in RPA has a 
different affinity of interaction with ssDNA and binds to different specific proteins (Table 1.1). 
 
   
  Figure 1.2.  Cartoon diagram of RPA70A OB fold domain.   
 
 
L12
L45
Basic cleft
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Table 1.1.  RPA domain organization, function and structures available.  
 
 Flexible linkers joining RPA domains provide great flexibility, which has precluded 
determination of RPA quaternary structure by NMR and X-ray crystallography. A simpler 
strategy has been effectively adopted.  The tertiary structures of RPA domains in various 
combinations have been determined (Table 1.1).  This approach, combined with functional 
analysis, has revealed much information about RPA function.   Based on this information, 
several models for RPA quaternary structure have been proposed [2-4].  However, in order to 
understand RPA dynamics and functional control, the spatial organization of the domains within 
the intact protein must be characterized.      
 
RPA ssDNA binding activity 
 As the universal cellular ssDNA binding protein active in DNA processing, RPA binds 
any ssDNA sequence.  RPA uses a sequence-nonspecific ssDNA binding mechanism involving 
   
Subunit Domains DNA 
binding
Protein 
binding 
Trimer
core
Fold Structure 
type
RPA70
N √ OB NMR
A √ √ OB Crystal
B √ √ OB Crystal
C √ √ OB Crystal
RPA32
N Disordered
D √ OB Crystal
C √ HLH NMR
RPA14 14 √ OB Crystal
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dynamic remodeling of the binding surface, coupled with RPA domains interacting with other 
proteins to advance DNA processing [5].   
 RPA binds ssDNA with 5’ to 3’ polarity as a result of the differences in its domain’s 
affinities for ssDNA [6].  RPA70A has approximately 10-fold higher affinity for ssDNA than 
RPA70B [7].  RPA70C and RPA32D affinities are weaker still.  However, due to the tethering of 
multiple domains and resulting high local concentrations, the combined ssDNA binding affinity 
of the RPA heterotrimer is in the low nM range [8].   RPA70A and RPA70B bind ssDNA in the 
OB-fold basic cleft, wrapping loops 1-2 and 4-5 around the ssDNA ligand [5].  RPA70A and 
RPA70B are connected by a 10 amino acid flexible linker, which promotes coupled binding of  
Figure 1.3.  RPA is composed of globular domains and flexible disordered linkers.  Each subunit 
is colored differently.  RPA70N is connected to RPA70AB and in turn RPA70C/32D/14 is 
connected to RPA32N and RPA32C.  Coordinates for this model have been obtained from Chris 
Brosey. 
70N
70A
70B
70C
32D
14
32C
32N
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RPA70A and RPA70B [7].  Although this step is sequential, due to intrinsic differences in 
binding affinities, the RPA70A and RPA70B binding events cannot be separated.  Hence, RPA 
DNA binding studies have shown that the first detectable binding mode consists of 8 to 10 
nucleotides, followed by second and third modes occluding 13 to 20 nucleotides, and 28 to 30 
nucleotides, respectively [8-10].  The X-ray crystal structure of RPA70AB in complex with dC8 
revealed that the first mode corresponds to RPA70AB binding [11].  It is proposed that 
sequential binding of RPA70C corresponds to the second binding event and the binding of 
RPA32D corresponds to the third step.  Although two X-ray structures of RPA32D/14 and one of 
RPA70C/32D/14 provide insights into structures [12-14], and  mass spectrometry finger printing 
analysis provided information on the distances spanning the ssDNA bound to RPA [15], exactly 
how the ssDNA threads onto the RPA domains has not been determined.  In all, this tri-modal 
mechanism establishes RPA’s canonical modes of ssDNA binding, which is conserved through 
the various DNA processing events in the cell.  
 
RPA-protein interactions 
 RPA was first identified as an essential component for the in-vitro SV40 replication 
system [16, 17].  This system of viral replication has provided a simplified model for the direct 
analysis of chromosomal DNA replication in eukaryotes.  Only one viral protein, the Large T-
antigen, participates in the process, which is otherwise entirely dependent on the host replicative 
apparatus [18]. Thus, the use of this cell-free system allowed the identification and 
characterization of the proteins involved in the eukaryotic replication activities [17, 19].   RPA 
was identified as necessary once ssDNA regions were generated at the origin of replication, and 
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it was determined that RPA facilitates the unwinding of parental DNA strands by the Large T-
antigen during the elongation phase of SV40 replication [17].  Since then, characterization of 
RPA interactions in the SV40 replication system has progressed considerably leading to a better 
understanding of eukaryotic replication, and the list of proteins that interact with RPA has 
become very extensive.  It is now known that the originally identified “replication” protein  A is 
utilized in a range of DNA processing events.  However, although many interactions have been 
reported, little work has been completed to fully characterize most of them.   
  In SV40 replication, RPA interacts with the SV40 large T-antigen (Tag) and the human 
DNA polymerase α-primase (pol-prim).  The interaction with Tag helicase is important for the 
loading of RPA onto ssDNA [20] while interaction with pol-prim is necessary for de novo RNA-
DNA primer synthesis.  Tag origin binding domain (Tag OBD) interacts with both the 
RPA70AB and RPA32C domain [21, 22].  Pol-prim p58C subunit also interacts with RPA32C 
(Sivaraja Vaithiyalingham, Erick Warren, Brandt Eichman and Walter J. Chazin, unpublished).  
Both of these interactions are necessary for initiation of replication to take place. 
 Other viral systems also utilize RPA during replication.  Papilloma viruses depend on 
host replication machinery for replication of their viral genome.  Papilloma virus proteins E1 
(functionally equivalent to SV40 T-antigen) and E2 directly bind RPA70 subunit [23].  The 
uncovering of other similar modes of binding can create a vision for the overall mechanism by 
which these events are regulated.      
 In homologous recombination, Rad51, the eukaryotic recombinase active in mitosis and 
meiosis, interacts with RPA70A through its N-terminus (Rad51N) at the same site as ssDNA, 
suggesting competition between ssDNA and Rad51N as a mechanism for displacement of RPA 
[24, 25]. Rad51 forms a nucleoprotein filament on the ssDNA and mediates displacement of 
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RPA in the initiation stage of genetic recombination [25].  Interestingly, RPA70A has greater 
affinity for ssDNA than Rad51N, which does not explain the exact mechanism for RPA 
displacement.   An additional RPA-Rad51interaction to RPA32/14 has been observed [24], and 
preliminary studies have narrowed these interactions to the RPA32C domain.  Moreover, an 
interaction of Rad51 with the RPA70C domain has been observed (M. Stauffer, D.I. Pretto, W.J. 
Chazin, unpublished results).  To our knowledge this is the only putative interaction to RPA70C 
that has been identified.  Rad52, a recombination mediator protein associated with RPA 
displacement mechanism in recombinatorial repair, also binds the RPA32C domain [26].  Rad52 
assists in Rad51 loading and in the formation of the Rad51 nucleoprotein filament on to the 
ssDNA [27].  BRCA2, another protein involved in regulation of Rad51 localization and DNA 
binding during recombinatorial double strand break repair, has also been shown to interact with 
RPA through its N terminus transcriptional domain, and this interaction is disrupted in mutant 
BRCA2 [28].  Mutations in BRCA proteins predispose women to familial breast cancer.   
 The same Rad52-interacting RPA32C binding interface is used by XPA (Xeroderma 
Pigmentosum complementation group A), and by the Nuclear Uracil-DNA Glycosylase UNG2 
[26].  These proteins are involved in different DNA repair pathways.  XPA is active in nucleotide 
excision repair (NER) where it recognizes DNA lesions.  RPA-XPA interaction enhances XPA’s 
affinity for damaged DNA and is necessary for repair to occur.  UNG2 is the major enzyme in 
base excision repair (BER) of deaminated cytosine (U/G) and possibly initiating BER of 
misincorporated uracil (U/A) [29].  The Rad52, XPA and UNG2 shared binding site lends 
support for the molecular hand-off mechanism [26] (see below).   
 RPA also binds transcription factors GAL4 and Vp16 through RPA70 subunit [30].  
Transcription factor and tumor suppressor P53 also interacts with RPA through the RPA70N 
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domain [31, 32].  P53 is reported to modulate the activity of Werner Syndrome Protein (WRN), a 
member of the Rec Q 3’to 5’ helicase family, which also harbors 3’ to 5’ exonuclease activity 
[33].  Defects in WRN activity result in rare premature age diseases and pre-disposition to 
various cancers.  Interestingly, WRN also directly interacts with RPA.  This interaction has been 
mapped to the RPA70N domain [34].  Related to WRN, Foci-Forming Activity 1 protein, (FFA-
1), the Xenopus laevis functional homologue of human WRN, is also thought to directly interact 
with RPA [35].   The assembly of RPA into X. laevis replication foci requires FFA-1, which is 
thought to stably associate with replication foci on nuclear chromatin and in so doing generates 
binding sites for RPA [36].  Yet another RecQ family member, the Bloom Syndrome Protein 
(BLM), which results in even more serious aging disorders and greater pre-disposition to cancer 
is also known to bind to RPA through the RPA70 subunit [37].  All this is consistent with our 
laboratory’s hypothesis that helicases assist in the loading of RPA on ssDNA as observed with 
the T-ag helicase [20]. Moreover, the interaction with RPA also influences the helicase activities.  
For example, RPA has been shown to stimulate WRN branch migration activity [38]. 
 More recently, RPA interactions with cell cycle checkpoint control proteins have been 
identified.  The ATR interacting protein, ATRIP [39], NBS1, Mre11 [40] and Rad9 [41] proteins 
interact with RPA through it RPA70N domain.  MRE11/Rad50/NBS1 complex as well as BRCA 
proteins, Rad51, Rad52 are all involved in early stages of double strand break repair.  RPA 
interaction with all these protein complexes suggests RPA may have activity as an orchestrator 
of the formation of repair foci (Figure 1.4).  
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Figure 1.4.  RPA protein-protein interactions that have been characterized. 
 
Disposition of RPA70N in the RPA ssDNA binding activity 
 RPA70N OB fold domain is similar to the other RPA DNA binding OB fold domains 
(RPA70ABC/32D) given is an OB fold with a basic surface that recognizes complementary 
acidic surfaces [42].  This property is important for the binding of target proteins.  It has also 
been proposed that RPA70N binds ssDNA [43, 44].  However, there is a critical difference.  
RPA70N lacks functionally conserved aromatic residues shown to be critical for 
32N
70N
70A
70B
32D
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RPA70ABC/32D interaction with DNA [1].  In particular, beyond the extensive network of 
hydrogen bonds, the RPA70A domain contributes two phenylalanine residues, F238 and F269, 
which form stacking interactions with the DNA bases to form a stable RPA-ssDNA complex.  
These aromatic residues are conserved in RPA70B, with W361 and F386 taking part in what the 
authors describe as a domino interaction, involving stacking of the aromatic residues with the 
DNA bases [45].  The conservation of these key amino acid residues is extended to RPA70C 
(Phe532 and Tyr581) and RPA32D (Trp107 and Phe135), which participate in the second and 
third mode of ssDNA binding respectively [14]. The RPA14 subunit is also an OB-fold and like 
70N it lacks aromatic residues in the basic cleft.  No DNA binding activity has been detected for 
the human RPA14 subunit. 
 In spite of the lack of aromatic residues in its basic cleft, a model has been proposed in 
which RPA70N is suggested to actively participate in the destabilization of the DNA double 
helix through direct binding to DNA [44]. DNA helix destabilization at origins of replication is 
necessary for the assembly of the replication machinery.  This process is described in two steps 
known as the nucleation step, which involves presumably binding of the protein and initial 
unwinding of the double helix creating a small ssDNA bubble; and the melting step, which is the 
extra dsDNA separation that leads to a double helix destabilization creating more ssDNA.   
 It is of importance to clarify that this RPA helix destabilization activity is not like the 
unwinding activities of a DNA helicase.  Helicases are proteins dedicated to rapidly and 
efficiently unpacking large stretches of dsDNA to give way to replication.  Massive amounts of 
ssDNA need to continuously be made available to the replication machinery and the RPA 
melting would not suffice in creating enough ssDNA.   A study aimed at understanding the 
mechanism by which RPA denatures pseudo-origin substrates (segments of DNA that contain 
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SV-40 origin of replication sequences) found that only a third of the substrates were denatured 
indicating that RPA could bind to the partial duplex substrates without causing their complete 
denaturation [46].  RPA can unwind approximately 30 base pairs of dsDNA by itself (nucleation 
step), and it was shown that it may load itself onto the ssDNA bubble [47, 48].  However, further 
studies have shown that rather, RPA is loaded on to the ssDNA by the Tag helicase (Jiang 2006).  
Overall, RPA is believed to stabilize the formation of ssDNA preventing it from forming any 
secondary structure or reforming a double helix.  This activity promotes partial denaturation of 
the origin of replication.   
 Interestingly, helix destabilization studies link RPA70N activities to the 
hyperphosphorylation of RPA32N domain.  In in vitro DNA helix destabilization experiments, 
an RPA70N knock-out mutant is defective in DNA nucleation and DNA strand separation during 
dsDNA helix destabilization steps that precede DNA replication [3]. The same is true when a 
pseudo-hyperphosphorylated RPA mutant is used in the reaction.   Previous NMR chemical shift 
perturbation experiments demonstrated a direct, although weak, interaction between 
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RPA70N and a synthetic pseudo-hyperphosphorylated RPA32N peptide [44].  Together, this 
lead to a hypothesis that RPA70N intersubunit interaction with hyperphosphorylated RPA32N 
domain removes RPA70N from its putative DNA bound location, and that this action causes a 
defect in DNA helix destabilization since RPA70N is no longer present to secure the RPA-DNA 
interaction that is thought to promote the initial unwinding of the double helix [44].     However, 
evidence in the literature also link RPA70N and hyperphosphorylation of RPA32N to regulation 
of RPA70N protein-protein interactions such is the case of RPA70N with the MRN complex 
[40].  It is more likely that hyperphosphorylation of RPA affects RPA functions through 
modulation of protein-protein interactions.  
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 The idea that RPA70N directly participates in helix destabilization binding to ssDNA is 
difficult to reconcile with RPA ssDNA binding mechanism.  The recognized RPA ssDNA 
binding domains, RPA70A, RPA70B, RPA70C and RPA32D, bind ssDNA with 5’ → 3’ 
directionality.   The ssDNA binding activity is initiated by the high affinity ssDNA binding 
domains RPA70AB, sequentially engaging RPA70C and RPA32D.  This sequential mode of 
binding is counter to the position of RPA70N in the intact protein.  In addition, multiple protein-
protein interactions have been identified through RPA70N.  I therefore set out to investigate 
RPA70N behavior in the ssDNA binding activity of the heterotrimer, which forms the basis of 
the studies described in Chapter II.   
 
Phosphorylation of RPA  
 Phosphorylation is a common mechanism of regulation of protein activity, and often 
occurs on more than one distinct site on a given protein.  A protein is said to be 
hyperphosphorylated when multiple sites are phosphorylated, and hyperphosphorylation of 
proteins during the cell cycle has been previously observed.  Cellular proteins including the 
tumor suppressor Rb (human) involved in checkpoint control and  the metaphase checkpoint 
protein Wee (human) are inactivated as a result of hyperphosphorylation [49]; other proteins 
appear to be activated by hyperphosphorylation [50].   RPA becomes partially phosphorylated 
(termed hypophosphorylated) during cell cycle activities and shifts to a hyperphosphorylated 
state as a response to DNA damage.  There is great deal of confusion about which kinases 
phosphorylate which RPA residues, the order of phosphorylation events and their outcomes.  
Therefore, as part of my studies, I have gathered all available information and attempted to 
reconcile the data to help in assessing the current state of the field. 
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 The possibility that RPA is post-translational modified was first investigated following 
the discovery that the unwinding of the origin of replication by T-antigen and cellular proteins 
was dependent on the cell cycle stage from which the cell extracts were isolated [51].  As a 
result, it was investigated if variations in the amount of RPA could account for this cell cycle 
specific unwinding activity; however, this was not the case.  The abundance of RPA remained 
unchanged throughout the cell cycle, but a cell cycle dependent phosphorylation of RPA was 
detected in human and yeast cells [52] and later in Xenopus oocyte extracts [53].  It was 
observed that phosphorylation was limited to the S and G2 phases of the cell cycle, but not the 
G1 phase with de-phosphorylation occurring late in mitosis, thereby resetting the 
phosphorylation cycle [52].   The association of RPA32 with the other two subunits, RPA70 and 
RPA14, was shown to be essential for phosphorylation to occur [52].  Interestingly, it has also 
been reported that phosphorylation dissociates the heterotrimer and its been speculated that 
phosphorylation and changes in subunit interaction are required for the proposed role of RPA 
during the polymerase switch at replication forks [54].  Table 1.2 provides a summary of the sites 
on RPA that are phosphorylated. 
 Although RPA phosphorylation was detected primarily on the RPA32N domain, 
phosphorylation has been observed in other RPA domains [55].  Up to five phosphorylation sites  
in the RPA70C subunit (Ser569, Thr580, Ser585, Thr590, and a single methionine), and one 
additional site in the RPA32D subunit (Thr98) were observed using a cocktail of kinases in vitro.   
However, these results were not reproduced in vivo when HeLa cells were arrested in S and 
G2/M transitions using aphydicolin followed by treatment with either hydroxyurea to stall 
replication forks or using UV light to cause ssDNA damage.  Instead, only phosphorylation in 
the RPA32N domain and a possible single phosphorylation site in the RPA70N-A linker region  
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Event 
 
 
Hypo- 
phosphorylation 
 
 
Hyper- 
phosphorylation 
 
Occurrence 
 
During normal cell cycle 
activity 
 
In response to ssDNA 
damage 
 
RPA32N phosphorylated 
residues 
 
Thr21, Ser23 
 
Ser4, 8, 11, 12, 13, 23, 29, 33 
Thr21 
 
Responsible Kinases 
 
 
Cyclin Dependent Kinases 
 
PI3K family of Kinases 
 
Table 1.2.  Summary of RPA phosphorylation and RPA32N residues involved.  
 
 
(between residues 112 and 157) were identified.  A specific functional role for the RPA70N-A 
linker phosphorylation has yet to be assigned [50].  It has been suggested that phosphorylation 
sites observed in vitro correlate with a normal process in cell cycle progression, however, 
previous studies have not identified modification in the RPA70 subunit during progression of the 
cell cycle [52].  Thus, much attention has been focus in understanding the phosphorylation of the 
RPA32N domain instead.   
 RPA32N is an unstructured region that harbors nine potential phosphorylation sites:  
Eight serines and one threonine (Ser 4, Ser 8, Ser 11, Ser12, Ser13, Thr21, Ser23, Ser29, Ser33). 
These residues are targets for phosphorylation by cell cycle checkpoint kinases and are 
presumably modified in a cell cycle dependent manner and as a response to DNA damage.  The 
specific role of these phosphorylation events has begun to be understood. The timing of 
phosphorylation suggests a regulatory role during DNA synthesis, but questions still remain as to 
how many and which sites are phosphorylated in the hyperphosphorylated state. 
 At least four distinct species of phosphorylated RPA have been identified based on their 
migration pattern on SDS-PAGE gels [56].  These have been called RPA32 Forms 2, 3, 4, and 5.  
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The non-phosphorylated RPA is referred to as Form 1.  Forms with increased level of 
phosphorylation travel slower in the polyacrylamide gels and are designated a higher number 
based on their slow speed of migration.  Form 5 therefore is the hyperphosphorylated RPA32.  
Form 2 and Form 3 are termed hypophosphorylated forms [57, 58].    
 To characterize the various RPA32N phosphorylation forms, SDS-PAGE gel patterns of 
purified and trypsinized RPA from non-irradiated and UV irradiated cells were compared.  These 
phosphopeptide maps show that Form 2 and Form 3 remain essentially the same pre or post UV 
irradiation, which suggests these hypophosphorylated RPA forms exist during normal cell cycle.  
Form 5 was most frequently observed post UV irradiation, and it was shown this 
hyperphosphorylated form contains the same phosphorylation sites from Forms 2 and 3 in 
addition to other sites.  A comparison of predicted phosphopeptide maps to the authentic maps 
was used as a tool to identify the possible residues involved in the various phosphorylated forms 
of RPA, identifying Thr21, Ser23, Ser29, Ser 33 and either Ser11, Ser12 or Ser 13 and probably 
Ser4 and Ser8 as sites of phosphorylation in the hyperphosphorylated form of RPA produced by 
UV irradiation.  For form 2, three phosphorylation events are proposed and at least five 
phosphorylation events for form 3 and seven for form 5 [57]. This is consistent with the notion 
that hypophosphorylated forms of RPA act as a precursor for hyperphosphorylated forms. 
 Evidence suggests that RPA hypophosphorylation is a normal cell cycle dependent 
process in regulation of replication.  Hypophosphorylation occurs at the replication initiation 
complex [59], beginning at the G1 to S transition phase with dephosphorylation occurring late in 
mitosis [52].  It has been shown that hypophosphorylated RPA has decreased interaction with 
DNA pol α, ATM and DNA-PK, and that it may have an effect in RPA binding to dsDNA at 
both damage and undamaged sites probably affecting RPA unwinding activity or, alternatively, 
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protein-protein interactions [60].  However, the primary activity of RPA is to bind ssDNA rather 
than dsDNA.  RPA binding to dsDNA was shown to occur via denaturation of thermally unstable 
cisplatin damaged DNA while binding to undamaged dsDNA was not significant [61]. Thus, 
during the normal progression of DNA synthesis RPA does not bind and unwind dsDNA. This 
putative RPA hypophosphorylation role in the regulation of RPA function in replication has not 
been investigated any further and more emphasis has been given to understanding the effect of 
hyperphosphorylation. 
 
 Hypophosphorylation of RPA by Cyclin Dependent Kinases 
 RPA becomes hypophosphorylated in a cell cycle specific manner under normal 
conditions by cyclin/cdk complexes.  The hypophosphorylation is thought to regulate RPA 
activity in DNA replication [52].  Cyclin 
dependent kinases (cdk) are 
serine/threonine kinases involved in the 
regulation of cell cycle, transcription and 
mRNA processing.   Activation of CDKs 
occurs through binding of cyclins, which 
are cell cycle proteins expressed at specific 
stages of the cell replication cycle (Figure 
1.5).  Cyclin-CDK active complexes then 
phosphorylate their targets controlling the 
progression of cells through the cell cycle.  
G1 S
G2 M
Cdk1
Cyclin B
Cdk4
Cyclin D
Cdk2
Cyclin E
Cdk2
Cyclin A
 
Figure 1.5.  Cyclins/cdk expression levels during cell 
cycle progression.   Figure 1.5.  Cyclins/cdk expression levels during cell 
cycle progression.   
18 
 
Analysis of the RPA32 primary structure implicated residues Ser23 and Ser29 as candidates for 
cyclin/cdk phosphorylation based on the established cyclin/cdk preferred substrate recognition 
sites (Ser or Thr followed by Pro) [62].   
 Cell cycle kinases are responsible for various RPA phosphorylation events during cell 
cycle progression.  Using cell fractionation techniques, cytoplasmic fractions from HeLa cells 
were purified that contained cyclin A and cyclin B related kinase activities.  These fractions were 
shown to be active in phosphorylating RPA32.  In addition, comparison of the levels of RPA32 
phosphorylation in mutant (Ser23→Ala and Ser29→Ala) and WT stable cell lines demonstrated 
that these residues are necessary for phosphorylation of RPA by the cdc2 kinase related activity 
in NH3T3 cells [63]. However, it is difficult to know with certainty which combination of 
kinases actively phosphorylate RPA in-vivo because cdc2 and cdk2 can both associate with 
cyclin A and cyclin B [64, 65].   
 Cyclin B/cdc2, cyclin A/cdc2 and cyclin A/cdk2 complexes were all able to 
phosphorylate RPA32 in-vitro [63, 65]).  Phosphopeptide mapping of an in-vitro phosphorylated 
and chymotrypsin digested RPA32 synthetic peptide containing residues 2-42 showed that the 
cyclin A/cdc2 complex can phosphorylate the same RPA32 peptides as the cyclin B/cdc2 
complex, and that these phosphorylation events were only a subset of all phosphorylation events 
identified in 293 cells.  These results revealed that other kinase activities could be involved in the 
phosphorylation of RPA, as was also observed by others [59].  Sequencing of the peptides 
confirmed that Ser23 and Ser29 were the targets for these cyclin dependent kinases and judging 
from the apparent levels of phosphorylation observed by SDS-PAGE gels, it can be inferred that 
cyclin B/cdc2 phosphorylation activity was more efficient than cyclin A related phosphorylation 
activity [63].  Similarly, in-vitro phosphorylation assays using purified cyclin/kinase complexes 
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demonstrated that the cyclin B/cdc2 complex was 5-times more efficient at phosphorylating 
RPA32 than the cyclin A/cdk2 complex [65].  Further, the in-vitro reconstitution of cdc2 and 
cdk2 kinase activities by addition of purified either cyclin A or B1 demonstrated that 
phosphorylation was only observed in the presence of cdc2 and not of cdk2 with either cyclin A 
of B1, and that phosphorylation in the presence of cyclin B1/cdc2 was again 4 to 5 times more 
efficient than phosphorylation by cyclin A/cdc2 [65].  These results lead to the conclusion that 
cyclin B/cdc2, and most likely cyclin A/cdk2, are the preferred combinations of cyclin/kinase 
complexes that phosphorylate RPA32 in the cell.  Interestingly, phosphorylation products 
resulting from addition of a fraction enriched with cyclin A/cdk activity (5S glycerol gradient 
fraction which also contained cdc2 as determined by immunobloting) or addition of 
commercially purified cyclin B/cdc2 were of similar sizes, indicating that the number of sites 
phosphorylated were similar [56] 
 Another study addresses the role of cdc2 and cdk2 in RPA phosphorylation during the 
cell cycle by examining the course of phosphorylation in Xenopus laevis egg extracts.  These 
cells are in a constant cycle between S and M phase, therefore lacking the G1 and G2 phases.  It 
was determined that cell cycle phosphorylation of RPA occurred during replication initiation 
because treatment with aphidicolin, a polymerase inhibitor, did not abolish phosphorylation of 
RPA in the nucleus despite arresting elongation.  Interestingly, RPA in the cytoplasm was not 
phosphorylated, thus it was concluded that the kinase phosphorylating RPA or a precursor for 
recognition by the kinase must reside in the nucleus [53].  Using immuno-depletion and rescue 
experiments it was determined that cdc2 phosphorylates free RPA during mitosis but not during 
S phase and that cdk2 is essential, but not sufficient, for phosphorylation of DNA-bound RPA in 
an S-phase dependent manner.  This indicated the existence of another kinase activity during S 
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phase and suggested that cdk2-mediated RPA32 phosphorylation does not occur in a direct 
manner.  These findings are consistent with previous evidence that cdc2 kinase phosphorylates 
RPA32 [63], and also that a kinase unrelated to cdc2 or cdk2 is involved in the phosphorylation 
of RPA32 [59, 63].   
 Cdc2 and cdk2 are cyclin dependent kinases with redundant roles in regulating G1/S 
transition.  Cdk2 is constitutively expressed in Xenopus egg extracts, however it was 
demonstrated that cdk2 cannot compensate for the loss of cdc2 in mitosis and its depletion from 
interphase extracts can block DNA replication during the initiation steps [66].  Consequently, it 
is generally established that cdk2 pushes cells through G2 and cdc2 in complex with cyclin B 
regulates the entry and exit to mitosis [64].  The kinetics of these kinases and the literature 
reviewed are therefore consistent with a cyclin A/cdk2-mediated RPA phosphorylation occurring 
during S phase and a cdc2-mediated RPA phosphorylation event occurring during G2-M phases 
of the cell cycle, as part of the normal cell cycle progression. 
 
Hyperphosphorylation of RPA as a response to DNA damage 
RPA hyperphosphorylation occurs when DNA damage is inflicted by UV, IR or chemical agents 
[57, 58, 67].  Moreover, transient HeLa cell transfections with wild type myc-RPA32 following 
knockdown of endogenous RPA32 by siRNA exhibit RPA foci formation at sites of DNA 
damage post UV irradiation as shown by colocalization with the DNA damage marker γH2AX.  
The same phenotype is observed when cells are transfected with a pseudo-phosphorylated 
RPA32 mutant (Ser→Asp), but not with a phospho-deficient mutant (Ser→Ala) that, instead, 
shows deficiency in foci formation [68]. This suggests that when RPA becomes 
hyperphosphorylated it remains localized with damaged DNA but the functional effect of 
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hyperphosphorylation on RPA function is not very well understood.  RPA-protein interactions 
seem to be altered when RPA is hyperphosphorylated, favoring RPA binding to proteins 
involved in DNA repair activities such as Rad51 and Rad52 [69], contrary to what is observed 
with the hypophosphorylated RPA and DNA pol α, reflecting a more avid binding of DNA repair 
proteins to hyperphosphorylated RPA.  These observations led to proposals that RPA 
hyperphosphorylation serves as a recognition signal for eliciting DNA repair responses.   
 The regulation of the phosphorylation state of RPA is also an active area of research.  
Recently, it has been shown that in cells recovering from hydroxyurea (HU) induced damage, the 
serine/threonine protein phosphatase 2A (PP2A) can dephosphorylate RPA, and although 
dephosphorylation does not appear to be important for normal checkpoint activation and re-entry 
into the cell cycle, persistent hyperphosphorylation of RPA results in defective DNA repair [70].  
Consistent with this, PP2AC has been used throughout the literature to dephosphorylate RPA in 
order to confirm that the bands in SDS-PAGE gels correspond to phosphorylated species.  
Similarly, protein phosphatase 4 complex (PP4) can also dephosphorylate RPA, and when PP4 is 
absent, elevated levels of hyperphosphorylation impede homologous recombination repair of 
double strand breaks by preventing loading of Rad51, thus increasing the cells susceptibility to 
DNA damaging agents [71].    Information regarding exactly which kinases phosphorylate RPA 
is much more complex, as there are a great number of studies and multiple kinases are involved 
in the phosphorylation of RPA.  RPA32N is hypophosphorylated by cyclin dependent kinases, 
and hyperphosphorylated by kinases active in the cellular response to DNA damage.  Evidence 
for the kinases implicated in these two separate RPA phosphorylation states is discussed in the 
next sections.    
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 Phosphatidylinositol-3 kinase-like (PI3-K) kinases are responsible for 
hyperphosphorylation of RPA.  It is well established that this family of Ser/Thr kinases is 
involved in the response of DNA damage.  DNA-dependent protein kinase (DNA-PK), ataxia 
telangiectasia mutated (ATM) kinase, and ATM- and Rad3-related (ATR) kinase are members of 
this family [71]. DNA-PK and ATM recognize damage to dsDNA and share similar sequence 
recognition patterns.  In cell studies, dsDNA damage is inflicted by used of ionizing radiation 
(IR) or bleomycin (a radiomimetic agent) or camptothesin (CPT), which trap topoisomerase 1 
cleavage complexes by obstructing their DNA interface creating a collision of DNA replication 
forks [72]. 
 ATR responds to a variety of damage signals that include intrastrand crosslinks, oxidative 
damage and polymerase toxins [73], thus mostly recognizing ssDNA damage. This type of 
damage can be inflicted by the use of UV (typically 10, 30, or 60 J/m
2
) or hydroxyurea (HU), 
which inhibits DNA replication by inactivating ribonuclease reductase.  ATR works in 
conjunction with the ATR-interacting protein (ATRIP), which is essential for all ATR activities 
[73].  Importantly, ATRIP is required for ATR’s localization to damage-induced foci [39]. 
Large-scale proteomic analysis demonstrated that these kinases phosphorylate a large number of 
proteins and identified more than 900 regulated phosphorylation sites encompassing over 700 
proteins [74].  RPA is a target of DNA-PK, ATM and ATR/ATRIP, resulting in the 
hyperphosphorylation of RPA.    
 The work presented in Chapter III is concerned with the hyperphosphorylation of 
RPA32N.  Our initial interest in RPA32N was motivated by observation that the NMR spectrum 
of the full length wild type RPA32/14 heterodimer in the presence of ssDNA showed the 
appearance of glycine resonances that belonged to RPA32N [26].  A similar result was observed 
23 
 
in NMR studies of full-length RPA, but only in the presence of ssDNA [4].  This data suggested 
that remodeling of RPA in the presence of ssDNA may result in the displacement of RPA32N, 
presumably allowing greater access to kinases.  Evidence of intersubunit interactions involving a 
synthetic RPA32N peptide that mimics hyperphosphorylation also indicated a potential for RPA 
remodeling involving RPA32N [44].  In addition, the fact that this negatively charged peptide 
could interact with the basic cleft of RPA70N suggested that RPA32N interaction may also be 
mediated through other RPA domains.  Together, these observations suggested RPA32N 
intersubunit interactions may be involved in some type of regulatory mechanism for RPA 
function.  I therefore set out to investigate intersubunit interactions involving RPA32N, as 
described in Chapter III.   
 
DNA-PK mediated phosphorylation of RPA 
 DNA Protein Kinase (DNA-PK) is a nuclear serine/threonine kinase composed of a 
catalytic subunit, DNA-PKCs, (470 kDa), and a DNA targeting factor, Ku70/Ku80 heterodimer or 
Ku antigen, (150 kDa).  Ku antigen binds at dsDNA break sites and recruits and activates DNA-
PKcs.  This positions DNA-PK near target proteins at DNA break sites, such as RPA.   
 DNA PK was first found to phosphorylate purified RPA in vitro following reports that 
cyclin dependent kinases can phosphorylate RPA [56].  Incubation of DNA PK with purified 
RPA in the presence or absence of ssDNA resulted in three slow migrating forms of RPA 
distinctly visualized on SDS-PAGE gels.  Comparing migration patterns to two slow migrating 
RPA forms from cyclin A/cdk or cyclin B/cdc2 mediated RPA phosphorylation, these 
experiments showed that DNA-PK phosphorylates RPA at different sites than the cyclin 
dependent kinases.   When purified RPA was co-incubated with DNA PK and either cyclin 
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A/cdk or cyclinB/cdc2, five RPA32 slow migrating forms similar to those observed when 
phosphorylation via DNA-PK incubation with cyclin A activated G1 extracts were observed.  
This suggests that the slowest RPA32 migrating forms result from the combined actions of cyclin 
dependent kinases and DNA-PK.  The same pattern was produced when DNA-PK is present in 
the G1 extracts prior to the addition of cyclin A or commercially purified cyclin B/cdc2. Since 
the faster migrating forms of phosphorylated RPA32 (attributed to the action of cyclin A or 
cyclin B/cdc2 complexes) accumulate earlier in the reaction than the slowest RPA32 migrating 
forms resulting from the combined action of DNA-PK and cyclin dependent kinases, it was 
proposed that there is a requirement for cyclin A/cdk activity for the phosphorylation of RPA32 
by DNA-PK.   However, in the absence of cyclin A, or when p21 (Cdk-interacting protein 1 or 
Cip1), a specific inhibitor for cyclin dependent kinases [75], was added to the in-vitro 
phosphorylation reactions, hyperphosphorylation of RPA was nearly abolished, but not 
hypophosphorylation [56].  Thus, it was proposed that cyclin A/cdk and not cdc2 activity may 
act as a precursor to DNA-PK-mediated RPA32 phosphorylation, perhaps by activating Ku 
antigen promoting DNA-PK activity.  It is also possible that cdc2 activity may be responsible for 
RPA32 hypophosphorylation that persists upon p21 treatment. 
 Given that RPA phosphorylation is dependent on cell cycle dependent kinases, in order to 
understand its role in regulation of DNA replication, the SV40 in vitro replication system was 
used to examine RPA phosphorylation and its effect in DNA replication in HeLa cells under 
genotoxic stress [58].  UV-induced DNA damage generated by a 10 J/m
2
 dose resulted in DNA 
replication arrest in HeLa cells for approximately 8 hours and complete recovery by 24 hours.  
However cell cycle progression in cells irradiated with 30 J/m
2
 doses did not recover after 24 
hours. The replication arrest was consistent with the appearance of primarily 
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hypophosphorylated forms of RPA, which decreased in concentration between 0 and 8 hours, 
appearing again at 12 hours and increasing in concentration up to 24 hours when 10 J/m
2
 dose 
was used, suggesting that these forms are important for recovery of replication activity. 
Hyperphosphorylated forms were observed as late as 18 hours after irradiation and remained 
constant until 24 hours when 10 J/m
2
 dose was used.   In contrast when 30 J/m
2
 dose was used, 
hypophosphorylated RPA decreased during the first 2 hours and did not reach high concentration 
by 24 hours.  The hyperphosphorylated forms predominated as early as 4-8 hours and persisted 
until 24 hours.  This suggested that hyperphosphorylated RPA is not active in replication.  
Notably, addition of purified RPA restored the replication activity, and SDS-PAGE analysis of 
the in vitro assays shows that the added RPA did not substantially increase the levels of 
hyperphosphorylated RPA form, but did increase the levels of hypophosphorylated forms.  Thus, 
exposure of HeLa cells to UV irradiation slows DNA synthesis and alters the phosphorylation 
pattern of RPA.  However, while the hyperphosphorylated RPA is not active in replication, SV-
40 in-vitro replication assays showed  that DNA replication activity was restored whether or not 
the hyperphosphorylated form of RPA is present, suggesting that its activity is not necessarily 
inhibitory [58].   
 Further confirmation of DNA-PK mediated RPA phosphorylation came from a study 
showing that DNA-PK immunodepleted extracts were unable to phosphorylate RPA32.  
However, immunodepletion of DNA PK had no effect on the extent of SV-40 replication in vitro 
[76].   This suggested that DNA PK is not involved in the hypophosphorylation of RPA.  Later 
studies, comparing two dimensional SDS-PAGE migration patterns  showed that, in-vitro, DNA-
PK can phosphorylate the same set of RPA32 phosphopeptides that are phosphorylated in HeLa 
cells after UV irradiation.  Comparison to predicted phosphopeptide maps suggested that the 
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phosphorylated residues in the observed peptides may include a combination of Thr 21 and Ser 
23, or Ser 29 and Ser 33, and one site on Ser 11, 12, or 13 [57].  Notably, a reduction of 70% in 
RPA phosphorylation was observed in the DNA PK in-vitro assays, which may be explained by 
the absence of cyclin dependent kinases in the in-vitro reaction, consistent with the cyclin 
kinases contribution to the overall phosphorylation of RPA.  Consistent with the DNA PK 
predictions, chemical sequencing and mass spectrometry analysis identified Thr21 and Ser 33 
RPA32N residues as the specific targets of DNA-PK phosphorylation [77].  These sites are 
consistent with the consensus preferred phosphorylation sequence for DNA-PK, a serine or 
threonine residue followed or preceded by a glutamine residue.   Additionally, this study also 
demonstrated that Ser29 is the predominant, although presumably not the sole cdc2 
phosphorylation site.  This is consistent with previous evidence suggesting that Ser29 was a 
target for cyclin dependent kinases as discussed above. 
  DNA-PK phosphorylation of RPA has also been studied in DNA-PK cell lines.  SV-40 
in-vitro replication assays using cytoplasmic extracts from HeLa, M059J (which lack DNA PK 
activity and have low expression of ATM), and AT cells (which lack ATM activity) treated with 
IR or CPT showed a reduction in replication activity [78].  The inhibition was only reversed 
when the extracts were treated with wortmannin, a non specific kinase inhibitor, either prior or 
post treatment and recombinant wild type RPA was added.  However, it was concluded that 
DNA PK mediated phosphorylation of Tag and not of RPA was the cause of the replication 
arrest, since reactions with phosphorylated RPA from HeLa cell extracts did not inhibit 
replication while reaction with phosphorylated Tag did.  Moreover, replication assays with a 32N 
knock out mutant had no effect on replication activity [78]. On the contrary, another study using 
the same in vitro assay using cytoplasmic extracts from M059K cells (which have normal levels 
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of DNA PKcs and ATM) and M059J cells showed a role for DNA PK in replication arrest 
through modulation of RPA activity [79].  Extracts derived from M059K cells 4 hours post UV 
irradiation exhibited reduced replication capacity.  However, they recovered replication capacity 
starting at 8 hours and full replication activity was observed at 24 hours post UV.  In contrast, 
although no decrease in replication was observed in M059J cells 4 hours post UV, a gradual and 
irreversible decrease in DNA replication activity was observed as early as 8 hours post UV and 
replication activity was minimal at 24 hours. The same gradual decline in replication effect was 
observed in M059K extracts of cells subjected to UV irradiation when they were incubated with 
20 uM wortmannin, a PI-3 Kinase inhibitor, preceding the replication assay.  Additionally, the 
effect is only attributed to DNA-PK and not other PI-3K kinases since addition of DNA-PK to 
DNA-PK-immunodepleted extracts resulted in replication arrest.   This lead to the conclusion 
that DNA-PK activity is involved in UV-induced replication arrest through modulation of RPA 
and may be is also important for restoring the replication activity.  The timing of these 
phosphorylation events in the replication reactions may explain why the previous study had 
opposing conclusions.  Moreover, the type of genotoxic stress used in these studies was different 
and the response mechanisms may be different as well.  
 
ATM-mediated phosphorylation of RPA 
 ATM kinase is necessary for the immediate response to DNA damage incurred in all 
phases of the cell cycle [80].  To determine its role in RPA activity several studies have used AT 
cell lines (defective in ATM) to probe the genotoxic stress induced hyperphosphorylation of 
RPA.  There are a number of different AT cell lines that code for inactive mutant ATM including 
AT3ABR, AT5ABR and AT5BI, which have known mutations, and AT3Be and AT2SF, which 
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have unknown mutations.  These have been used to assess the necessity of ATM in RPA 
phosphorylation in various studies.  GM08436, GM01526 and GM03189 cells are homozygous 
for AT mutations and don’t express ATM [67].  AT3ABR, AT5ABR, and AT2SF do not express 
detectable levels of ATM and low levels are expressed in AT5BI [81].  AT5BIVA and AT3BISV 
cells are also defective in ATM [82]. 
 Rapid RPA hyperphosphorylation was observed in response to ionizing radiation when 
Raji cells exposed to 10, 50 or 100 Gy of IR, pulsed with 
32
P and immunoprecipitated with 
RPA32 or RPA70 monoclonal antibodies. [67]   Phosphopeptide mapping of S/G2 
hyperphosphorylated RPA in comparison to the species resulting from γ irradiated cells showed 
these contained the same peptides, and sequencing revealed that only serine residues were 
phosphorylated.  Hyperphosphorylation occurred mainly in G1 phase and diminished through S 
phase, and it was estimated that cdc2 phosphorylation at Ser23 and Ser29 is required for γ 
induced phosphorylation mediated by ATM.  The phosphorylation of RPA in response to low γ 
doses was seen after 2 hours in AT cells (GM08436, GM01526, and GM03189).  This is very 
fast compared to normal cells, in which hyperphosphorylation was not noticeable until after 45 
minutes.  Similarly, using 5kJ/m2 of UV, hyperphosphorylation was observed as early as 2 hours 
[67]. 
 ATM immunoprecipitated from HeLa cells irradiated with 10 Gy ionizing radiation (IR) 
supplemented with DNA was shown to phosphorylate RPA32 in-vitro.  This was further 
corroborated by the inability of AT2SF immunoprecipitates to phosphorylate RPA.  
Additionally, no phosphorylation of RPA32 was observed in the absence of the added mixture of 
ssDNA and dsDNA [81].  Stimulation of this phosphorylation reaction by DNA was 
corroborated by others showing that M13 single stranded closed circular DNA, in the presence of 
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sheared DNA, greatly stimulated ATM-mediated in-vitro RPA32 phosphorylation in assays 
containing ATM isolated from human placenta in the presence of MnCl2 [83]. This is consistent 
with the notion that ATM binds dsDNA prior to phosphorylating its targets.  Two dimensional 
phosphoamino acid analysis showed that ATM phosphorylates threonine and serine residues of 
RPA [81]. 
 The timeline for RPA hyperphosphorylation observed in two human skin-derived normal 
fibroblasts cell lines,  LM217 and GM00637, irradiated with 10 J/m
2
 UV [82] was similar to that 
observed in HeLa cells [58].  While hypophosphorylation of RPA remained throughout the cell 
cycle up to 32 hours after irradiation, hyperphosphorylation occurred after 4 hours, peaked at 12 
hours, and remained up to 32 hours post irradiation.  However, UV induced RPA 
hyperphosphorylation was not observed in AT5BIVA and AT3BISV cells up to 24 hours after 
UV irradiation with 30 J/m
2
, but inducible expression of ATM restored the hyperphosphorylation 
of RPA.   SDS-PAGE analysis shows RPA hyperphosphorylation in AT cells exposed to 10 J/m
2
 
UVC is less robust after 8 hours post exposure.  Cell lysates from asynchronous AT3BISV cells 
show that the hyperphosphorylated RPA (form 5) exist both pre- and post-UVC irradiation, 
reaching maxima approximately 12 hours post irradiation.  However, only very faint bands are 
observed and it appears that RPA form 5 is fainter after UV induction than before.  In contrast, 
nuclear extracts from the same cell line are free of the hyperphosphorylated RPA at 8 hours, 
hence their claim that RPA hyperphosphorylation is not detected.  It should be noted these gels 
are not shown at later time points as in complete cell lysates. 
 ATM deficient AT1ABR cells engineered into ATM inducible cells undergo 
hyperphosphorylation 8 hours post a 30J/m2 dose of UV irradiation.  Accordingly, they failed to 
observe RPA32 hyperphosphorylation when ATM expression is reduced by at least 50% in cells 
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that normally express ATM.   Moreover, normal lymphoblast cell lines transfected with an 
inducible antisense ATM cDNA expression vector, C3ABR cells, were defective in RPA 
hyperphosphorylation.  Hypophosphorylated forms of RPA did not seem to depend on ATM 
kinase activity.  All this indicated that ATM kinase targets RPA [82].  In addition to this, MH59J 
cells not only lack DNA PK but also have low ATM activity, which indicated that the low 
hyperphosphorylation activity observed could be a consequence of either DNA PK or ATM 
activity.   It was also shown that hyperphosphorylation of RPA 32 is dependent on ongoing 
replication, since inhibition of DNA replication by addition of aphidicolin prevented induction of 
RPA hyperphosphorylation.   In addition to this purified ATM was shown to phosphorylate RPA 
in vitro at many of the same sites of phosphorylation observed in vivo in response to IR.  Two 
dimensional peptide maps showed that ATM phosphorylates RPA at multiple sites and although 
some appear to be the same as DNA PK, there are some differences [82].   ATM substrate 
specificity in in-vitro phosphorylation reaction was compared to that of DNA-PK using two 
dimensional peptide maps of hyperphosphorylated RPA.  The differences observed between the 
ATM and DNA-PK RPA32 phosphorylation are obvious.  However a pattern obtained from both 
kinases together combines the peptides observed from maps of each individual kinase suggesting 
that both are active in the hyperphosphorylation of RPA.  Interestingly, the levels of DNA-PK in 
ATM mutated cell lines is comparable to that found in wild-type cells, however the contrary is 
not true.  Endogenous levels of ATM are reduced in the M059J DNA-PKcs deficient cells but 
not in the M059K DNA-PKcs expressing cells.  Thus, ATM could also contribute to the reduced 
RPA32 hyperphosphorylation observed in DNA-PKcs- M059J cells.  However, whether ATM 
driven RPA hyperphosphorylation is a direct or indirect effect was not clarified.   
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 The type of DNA damaging agent used to elicit RPA hyperphosphorylation can result in 
a different response.  IR and Camptothesin (CPT) treatments result primarily in dsDNA breaks 
whereas UV causes mutation and ssDNA damage, therefore the kinases recruited in each event 
may be different.  CPT induces replication dependent DNA lesions by trapping topoisomerase I 
cleavage complexes and resulting in the arrest of cells in the S and G2 phases of the cell cycle  
[84].  CPT treated AT-fibroblast and ATM normal fibroblasts have the same level of RPA 
hyperphosphorylation, suggesting that CPT induced RPA hyperphosphorylation is not ATM 
dependent [84].  Dominant negative ATM cells, expressing a non functional ATM protein, have 
a 5-fold increase in DNA-PK activity post CPT treatment and DNA-PK kinetics coincide with an 
increase in RPA32 phosphorylation suggesting that DNA-PK hyperphosphorylates RPA32 in 
response to CPT treatment.  In addition, aphidicolin, a DNA polymerase inhibitor blocked CPT- 
and IR (18 Gy)-induced RPA32 hyperphosphorylation.   Therefore, when replication is halted at 
the elongation step, replication dependent DNA lesions caused by CPT or IR will not result in 
RPA hyperphosphorylation.  Thus, for the kinases to phosphorylate RPA in response to IR and 
CPT induced damage, replication must be ongoing.  This is consistent with DNA-PK-mediated 
phosphorylation occurring at S phase of the cell cycle.  A common denominator in replication 
defects is the generation of ssDNA that becomes immediately coated by RPA.  When double 
strand breaks occur, in order to repair the damage, the DNA is resected and ssDNA is generated. 
This intermediate is targeted by other kinases such as ATR and ATRIP complex.  This prompted 
studies of the possibility that these kinases are involved in RPA phosphorylation in response to 
DNA damage. 
 
ATR-mediated phosphorylation of RPA 
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 The yeast ATR homologue, MEC1, has been shown to be important for phosphorylation 
of RPA during normal cell cycle and also in response to UV and ionizing radiation (IR) [85].  In 
that study, yeast RPA phosphorylation was monitored in cells deficient for MEC1, Mec1-1 cells.  
While MEC1 expressing cells exhibited RPA phosphorylation 30 minutes after release from G1 
phase, which corresponds to the entrance to S phase of cell cycle, RPA failed to become 
phosphorylated in Mec1-1 cells.  Curiously, in spite of this difference both cell lines progressed 
through the various phases of cell cycle with identical kinetics as shown by flow cytometry.  
These results indicate that ATR may be involved in the initial steps of RPA phosphorylation 
during the S-phase of cell cycle progression.  Moreover, in the presence of HU, IR, or 60 J/m
2
 
UV irradiation, the MEC1-1 cells exhibited a deficient level of RPA phosphorylation compared 
to MEC1 cells.  The authors estimate that the mobility of this phosphorylated form of RPA in 
SDS-PAGE gels is different from other forms observed on normal cells.  The low resolution of 
the gels makes it difficult to estimate if this band is a hypo or hyper phosphorylated form of RPA 
or a mix.  In HU treated cells, TEL1 (the ATM homologue) was shown to only partially restore 
RPA phosphorylation in the absence of MEC1 while a MEC1-TEL1 double deletion resulted in 
no RPA phosphorylation.  However, addition of MEC1 restored RPA phosphorylation in the 
double mutant cell line.  This seems to indicate that ATR phosphorylation of RPA is important 
for RPA hyperphosphorylation in response to DNA damage and that this kinase activity is 
independent from the ATM kinase but may have a functional relationship.  ATR kinase is 
necessary to achieve normal levels of phosphorylation regardless of ATM activity, while ATM 
activity does not seem to be necessary for a full ATR response after HU treatment. Interestingly, 
the same group reported later that phosphorylation of RPA 70 subunit is also observed in 
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response to HU but unlike RPA32 phosphorylation, RPA70 phosphorylation is not normally 
present during the cell cycle [86]. 
 ATR participation in RPA32 hyperphosphorylation has also been studied in human cells 
[87].  Using an SV40 transformed fibroblast cell line (GM847) expressing a doxycyclin 
inducible kinase-inactive allele of ATR, it was demonstrated that, in response to UV or HU, 
RPA32 hyperphosphorylation was reduced upon over-expression of the kinase-inactive allele.  In 
addition, SDS-PAGE analysis of RPA32 detected with phospho-specific antibodies against Ser4, 
Ser8, and Ser33 demonstrated that phosphorylation levels on these residues were reduced.  
Interestingly, Thr21 and Ser33 are ATR consensus sites but Ser4 and Ser8 are not.  Although this 
demonstrates that absence of ATR affects phosphorylation of RPA, it is important to mention 
that over-expression of the kinase inactive allele of ATR also resulted in loss of Chk1 
phosphorylation by ATR, which is necessary for Chk1 activation. Ser→Ala mutations on Ser 4, 
Ser8, Ser11, Ser12, and Ser13 do not abolish ATR phosphorylation of RPA32, but Ser→Ala 
mutations of Ser33 or Thr21 do.  This suggests that ATR directly phosphorylates RPA32 Ser33 
and Thr21.  The contribution of other PI3K kinases was also investigated in this study by using 
retroviral infection of siRNAs in U2OS cells against DNA-PK and ATM in parallel with ATR 
and also Chk1.  RPA32 hyperphosphorylation was monitored after UV and HU treatments 
demonstrating that depletion of DNA-PK, ATM or Chk1 does not affect the overall levels of 
UV- or HU-induced RPA32 hyperphosphorylation, but more specifically phosphorylation of 
Ser4, Ser8 and Ser33.   Interestingly, RPA32 phosphorylation was reportedly increased when 
Chk1 expression was knocked down.  The authors point out the consistency with reports that 
Chk1 inhibition results in an increase of ATR activity [87, 88].  A similar observation was made 
in Chk1 depleted human colon cancer HCT116 cells arrested in S-phase.  Inhibition of 
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replication by addition of thymidine to these cells resulted in accumulation of RPA foci, 
primarily in the hyperphosphorylated form [89]. 
 It has been demonstrated that RPA-coated ssDNA serves as an intermediate to stimulate 
ATRIP binding to ssDNA.  RPA70 expression is necessary for ATR/ATRIP localization to sites 
of DNA damage induced by IR [90]. The same study also showed that in-vitro RPA-coated 
ssDNA is an important intermediate for the activation of ATR substrates such as Rad17, which is 
phosphorylated at Ser635, and Chk1 kinase, which is phosphorylated at Ser345.  In this study, 
chromatin fractions of RPA70 siRNA HeLa cells exhibited a loss of phosphorylation of the Chk1 
kinase post UV irradiation.  Interestingly, a more recent study in SW80.SN3 cells (human 
colorectal carcinoma cell line) showed no effect in soluble fractions from RPA70 siRNA on 
Chk1 phosphorylation after DNA damage induced by HU [91].  It is possible that the type of 
DNA damage inflicted in these two events caused a different ATR activation response or that the 
response is localized to the nucleus and the effect was overlooked in soluble fractions.  Thus, 
although ATR activation does not always occur via ssDNA-RPA recruitment of ATRIP, there is 
no evidence that suggests that the ATR-mediated phosphorylation of RPA32 post DNA damage 
is dependent on the activation pathway for ATR.  ATR directly phosphorylates Ser33 and Thr21.  
It also has an indirect effect on phosphorylation of Ser 4, Ser8, Ser11, Ser12, and Ser13.  
Whether or not Chk1 is involved in the phosphorylation of these residues is not known. 
However, observations that RPA32 hyperphosphorylation is increased in the absence of Chk1 
suggest that this is not the case. 
  In summary, RPA32 residues Ser4, Ser8, Ser11, Ser12, Ser13, Thr21, Ser23, Ser29, and 
Ser33 are targets for phosphorylation by cellular kinases.  Cyclin dependent kinases 
phosphorylate Ser23 and Ser29 during cell cycle progression, with Ser29 is the preferred site for 
35 
 
cyclin B/cdc2. DNA-PK, ATM and ATR all have the capacity to phosphorylate Thr21 and Ser33 
in response to DNA damage.  Phosphorylation of Ser4 and Ser8 may also depend upon ATR and 
DNA-PK. In-vitro, DNA-PK is able to phosphorylate all of these residues.  Cyclin A/cdk is a 
DNA-PK precursor for RPA32 phosphorylation.   It seems more and more apparent that the type 
of genotoxic stress inflicted dictates which kinase will respond to phosphorylate RPA.  The 
literature points to PI3-K kinases DNA-PK, ATM and ATR being involved in DNA damage 
hyperphosphorylation of RPA32.  IR causes double strand breaks and the repair of this type of 
damage requires the resection of the strands to generate single stranded DNA that is then coated 
with RPA.  ATM is a kinase responsive to dsDNA breaks and IR-induced hyperphosphorylation 
of RPA is dependent on ATM.  However, upon resection of the strands, other kinases such as 
ATR may also be involved. In contrast, UV- and HU-induced hyperphosphorylation of RPA32 is 
largely ATR dependent.  Both cause ssDNA formation, although we cannot disregard that DNA-
PK and ATM may also be involved in RPA phosphorylation with these types of damage.  
Blocking DNA replication elongation by treatment with aphidicolin resulted in lack of DNA-PK-
mediated RPA hyperphosphorylation and persistence of hypophosphorylated forms of RPA32.  
In addition, aphidicolin also blocks CPT and IR induced RPA hyperphosphorylation.   Together, 
these data indicate that hyperphosphorylation occurs during the S phase of cell cycle while RPA 
is loaded on the ssDNA and replication is ongoing.  Hypophosphorylated forms of RPA are a 
precursor for the hyperphosphorylated RPA generated in response to the type of damage 
inflicted.   It is possible that the work of these kinases in phosphorylating RPA overlaps to ensure 
that a response mechanism is triggered in any event in which DNA damage is produced, 
initiating a cascade of events through RPA interactions leading to repair of the damage in 
actively replicating cells.  
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Experimental Methods 
  
Small Angle X-Ray Scattering (SAXS) 
 SAXS is a powerful structural technique for the study of macromolecular systems, 
especially those which represent a challenge to more established techniques such as NMR and X-
ray crystallography.  Moreover, SAXS has proven extremely valuable when used in combination 
with these complementary structural techniques, allowing the description of structures and 
conformational changes associated with different functional states of macromolecules and 
molecular complexes [92, 93].   
 SAXS experiments can be performed on a broad range of samples, included proteins 
from ~10 to 300 kDa in size [94].  During the SAXS experiment, a 2-10 mg/ml protein solution 
(concentration depends on the protein size) is exposed to x-rays and the scattering intensity (I) is 
 
Figure 1.6.  Representation of  SAXS data collection.  An intense beam scatters electrons from 
the protein solution and scattering intensities are recorded by an image detector.  Raw scattering 
data for RPA70AB is shown.  The yellow arrow indicates the beam stop.  Scattering intensities at 
low angle are surrounding the beam stop.  Scattering intensities at higher angles are more distant 
from the beam stop. 
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recorded as a function of the scattering angle (q) (Figure 1.6).  Because of the random positions 
and orientations of each protein particle, the intensity is isotropic and proportional to the 
scattering from a single particle averaged over all orientations [94].   
 Once data is collected the contribution from the solvent is removed by subtracting 
scattering intensities from the solvent alone from scattering intensities of the sample, leaving 
only the scattering intensities of the protein.  These are then spherically averaged to obtain the 
scattering profile of the protein particle.  This procedure highlights the importance of performing 
these experiments with pure monodispese samples, as it would be impossible to separate the 
scattering from impurities, aggregates or polydisperse samples.  Moreover, scattering intensities 
will be dominated by the solvent, thus appropriate concentrations are necessary to obtain good 
intensity signals for the solute. 
 A log plot of the protein scattering intensities, I(q), as a function of the scattering angle, q 
(Å
-1
), gives us the SAXS profile for the protein in reciprocal space (Figure 1.7a).  Scattering data 
at higher angles (larger q values) correspond to scattering that is far from the beam stop and 
contains detailed structural information about the protein shape [92].  Scattering data at the 
lowest angles (small q values) corresponds to data closest to the beam stop, and is used to check 
against aggregation that may arise during data collection.  Guinier analysis for globular proteins 
(Figure 1.7b), or Debye Formula for elongated proteins, is used to check for aggregation.   
Guinier analysis also allows estimating the radius of gyration (Rg) of the protein directly from 
the scattering data.  Rg is the radial space occupied by the protein based on its center of mass.  
Other types of analysis are also possible that estimate the Rg and hydrated volume of globular 
proteins, such as the Porod invariant (Figure 1.7c).  Because globular proteins have uniform 
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electron densities, their molecular weight is directly related to their volume [92].  Porod volume 
in nm
3 
corresponds to approximately twice the molecular weight of the protein in KDa. 
 Kratky analysis, a plot of q
2
*I(q) as a function of q,  is another useful tool derived directly 
from the scattering data (Figure 1.7d).  For well folded samples the plot has a parabolic 
appearance, q
2
*I(q) values converge back to zero at large q.  For unfolded samples it reaches a 
plateau with high q
2
*I(q) values at large q and partially unfolded proteins fall in between [92].  
Kratky profiles for flexible proteins, such are RPA70NAB and RPA70AB, show an inherent 
degree of randomness with q
2
*I(q) higher than zero, but far from high q
2
*I(q) values [95].  
Therefore, this type of analysis can be used assess the degree of flexibility, the presence of 
disorder, and conformational change [93]. 
 
Figure 1.7.  Analysis of SAXS data:   (a) Scattering plot; (b) Guinier analysis; (c) Porod 
analysis; (d) Kratky analysis. 
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 Further transformation of the scattering data produces the P(r)-distribution function, a 
plot that describes the distribution of inter-atomic distances, P(r), in real space, r (Å).  P(r) is 
sensitive to the shape of the molecule under study (Figure 1.8).  The maximum dimension 
(dmax) of the particle is one of the key characteristics that can be obtained from the P(r) 
function, and like Rg, is a useful description of the molecule under study.  Low resolution three- 
dimensional ab initio models can also be generated either directly from the scattering data or the 
P(r) function.    To construct the three dimensional model, GASBOR uses the scattering data to 
fit a chain of dummy residues, much like a chain of amino acids, within a spatial arrangement 
that satisfies the SAXS data [94].  Similarly, DAMMIN uses an ensemble of densely packed 
beads and simulated annealing to find a configuration that fits the SAXS data [96].  Due to the 
inherent imprecision, 10 GASBOR or DAMMIN models  are typically averaged (i.e. using 
DAMAVER) (Figure 1.9).  The fit of these conformational envelopes onto known crystal or 
NMR structures can be used to assess consistency.  In our research, we found that these 
calculations cannot be applied to highly flexible systems, such as RPA70AB (unbound) and 
RPA70NAB, because intrinsic interdomain flexibility is not accounted for in these models.  
Rigid body molecular dynamics is a common approach used to generate conformational 
ensembles for proteins with substantial inter-domain flexibility.  BILBO-MD is one such
 
Figure 1.8.   P(r) is sensitive to the shape of the molecule under study 
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program, and was used in our studies.  It uses CRYSOL to backcalculate a scattering profile for 
each conformer.  The fit between the calculated and experimental scattering curves are then used 
to evaluate how well each conformer matches the experimental data, as reflected in a χ2 fitting 
parameter.  The Minimal Ensemble Search (MES) program can be applied to assess whether 
multiple conformers provide a better fit to the data than single structures.  However, as will be 
discussed in Chapter II, it is not possible to distinguish the relative merit of one conformational 
subset over another [95, 97].  
Figure 1.9.  SAXS envelope of RPA70AB bound to ssDNA. 
 
Nuclear Magnetic Resonance (NMR) spectroscopy 
               Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful means to characterize 
the structure and dynamics of molecules [98-103].  One particularly useful application of NMR 
is for the study of weakly interacting systems, including protein-protein interactions.  Chemical 
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shift perturbation is the most widely used method to map protein interfaces through the 
identification of the residues involved in an interaction.  In this experiment, a 2D 
15
N-
1
H HSQC 
(Heteronuclear Single Quantum Coherence) spectrum of an 
15
N-enriched protein (Figure 1.10) is 
monitored when the unlabeled interacting partner is titrated in.  Signals correlating the 
1
H 
chemical shift to the 
15
N chemical shift appear in the 2D spectrum for every backbone and side 
chain amide in the protein.   The perturbations of the chemical shift resulting from changes in the 
environment surrounding a residue, as a consequence of the interaction with the titrant, are 
recorded for every titration point.  Perturbations of the signal arise in the spectrum in the form of 
broadening of a peak, disappearance of a peak, or shift in peak position.  The kinetics of the 
interaction determines the change in chemical shifts during the titration.  Peaks are broadened as 
a result of intermediate exchange, whereas in slow exchange one set of peaks disappears from 
the spectrum as a second set appears at a different position.  Fast exchange, which is often 
observed for weaker binding interactions, results in constant shifting of peak positions.  This 
refers to a fast dissociation of the complex and thus a single set of resonances is observed at all 
times.  
 In all NMR spectroscopy experiments, it is important that the protein samples are of high 
purity and high concentration starting from at least 100 uM to 500 uM. Since ~0.5 mL of 
solution is required, there is a need for large amounts of protein, which could present a problem 
for some proteins.  The pH of the protein solution must be maintained during the experiment to 
maintain a stable chemical environment and avoid chemical shift changes for reasons that are not 
a by-product of intermolecular interaction.  Using the same buffer for both proteins eliminates 
this problem.  This method is suitable for a range of proteins.  Although it can be manipulated 
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Figure 1.10.  2D 
15
N-
1
H HSQC spectrum of 
15
N-enriched RPA70AB.  
to identify resonances of proteins larger than 30 KDa size, its sensitivity is most optimal for 
proteins of lower molecular weight.  Throughout my research, chemical shift perturbation 
experiments have been used to investigate RPA32N interaction with other RPA domains.   
              In addition to mapping the interface, the titrations allow the estimation of affinities, 
stoichiometry and specificity of binding.  The dissociation constant can be calculated by 
following the resonances to the bound position and fitting the fractional shift against a quadratic 
equation depending on the total protein and partner concentrations.  The equation is derived from 
the formula KD = ([Ptot] - [PA])([A tot] - [PA]) / [PA], where P is the protein, A is the interacting 
partner and PA is the bound complex. 
 Resonance assignments are an essential first step for any detailed study by NMR.  
Assignments are required in order to map chemical shift perturbations on the structure of the 
protein under study.  NMR chemical shift assignments can be obtained using a variety of 
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strategies and these have been amply reviewed [98].  In my studies, a series of 3D 
15
N-
13
C-
1
H-
triple resonance NMR experiments including HNCA, HNCO, HN(CO)CA, HNCACB, and 
CBCA(CO)NH were collected to complete backbone assignments for RPA32N.  Once the 
resonances have been assigned, the chemical shift perturbations can be related to the protein 
structure and the binding interface delineated.    This in turn allows a highly efficient, direct 
approach to designing mutations to assess the functional significance of the interaction under 
investigation. 
 
Research Overview 
 This dissertation focuses first on the influence of RPA70N on the structural dynamics of 
the high affinity ssDNA binding domains RPA70AB and effect of hyperphosphorylated 
RPA32N on the overall architecture of RPA. These studies are aimed at understanding how RPA 
domains participate in RPA functional activities.  In Chapter II we address an ongoing 
controversy about the role of RPA70N in the ssDNA binding activity of RPA.  I have 
approached this question using SAXS and molecular dynamics to demonstrate the disposition of 
RPA70N within the context of RPA70NAB in the absence and presence of ssDNA.  In 
RPA70NAB, the linker between RPA70N and RPA70A is 60 residues, and the linker between 
RPA70A and RPA70B is 10 residues.  Protein purification and stable buffer conditions were 
optimized for the RPA70AB control and RPA70NAB.  SEC-MALS was used to assess protein 
monodispersity, an essential prelude to SAXS analysis.  The ssDNA binding properties of these 
two RPA constructs were analyzed.   All SAXS data were collected at the SYBILS beam line 
located at Berkley National Laboratory in collaboration with Dr. John Tainer’s research group, 
specifically with Dr. Susan Tsutakawa.   An RPA70NAB model was constructed based upon 
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crystal structures of RPA70AB + ssDNA and RPA70N.  Molecular dynamics simulations using 
SAXS data to guide the conformational search demonstrated the inherent flexibility of the linkers 
and dynamic properties of RPA70NAB.  These studies showed RPA70N does not to interact 
with ssDNA even in the presence of high local concentrations of ssDNA accessible for binding.    
This work also illustrated the difficulties of SAXS analysis in flexible systems. 
 Studies described in Chapter III identify RPA32N inter-domain interactions in the 
hyperphosphorylated state of RPA.  This work is aimed at understanding what intersubunit 
interactions are relevant for the analysis of RPA’s actions in response to DNA damage. An 
RPA32N phosphomimetic mutant peptide (RPA32N-D8) was constructed and characterized. 
Recombinant pseudo-phosphorylated and wild type RPA32N peptides were produced and 
potential intersubunit interactions were systematically tested using NMR chemical shift 
perturbation assays.  RPA32N-D8 was found to interact with RPA70N, RPA70A and RPA70B 
domains, but not with RPA32C, RPA32D, and RPA14 domains.  An interaction with RPA70C 
could not be confirmed.  Residues involved in the intersubunit interactions were compared 
against residues involved in ssDNA and RPA-protein interactions.  I also extended the analysis 
to preliminary experiments on a full-length RPA phosphomimic protein.   A full-length RPA 
hyperphosphorylation mutant was constructed in collaboration with SBDR at Berkley National 
Lab.  Preliminary SAXS data was collected for the hyperphosphorylated mutant.  These data 
suggested a model in which hyperphosphorylation of RPA causes a compaction of the protein.   
 Finally, the data presented in this thesis are discussed in Chapter IV.  Overall, my 
research advances our understanding of how the properties of RPA domains influence RPA 
function, and provide a foundation for analysis of dynamic RPA actions in DNA repair.   
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CHAPTER II 
STRUCTURAL DYNAMICS AND SINGLE-STRANDED DNA BINDING ACTIVITY OF 
THE THREE N-TERMINAL DOMAINS OF THE LARGE SUBUNIT OF 
REPLICATION PROTEIN A FROM SMALL ANGLE X-RAY SCATTERING* 
 
Introduction 
 RPA is the primary eukaryotic ssDNA binding protein utilized for diverse DNA 
transactions in the replication and maintenance of the genome [reviewed by Fanning and co-
workers [104]]. RPA functions by binding and protecting ssDNA from degradation by 
endonucleases, inhibiting formation of ssDNA secondary structure, and providing a scaffold for 
DNA processing machinery by interacting with numerous DNA processing proteins. RPA 
biochemical functions and biological activities have been intensively investigated and the 
structures of its domains determined [11-14, 26, 42, 45, 105]. Despite this detailed information, 
the mechanisms for RPA function remain poorly understood, largely because of the inherent 
difficulties of characterizing proteins with modular organization and the fact that RPA function 
is integrated within complex multiprotein machinery. 
 RPA is a modular 116 kDa heterotrimer composed of seven structured globular domains 
and one disordered domain (Figure 2.1). The trimer subunits are named on the basis of their 
approximate molecular masses: RPA70, RPA32, and RPA14. The RPA70 subunit contains four 
oligonucleotide-oligosaccharide binding (OB-fold) domains: RPA70N, RPA70A, RPA70B, and 
RPA70C. RPA70N is linked to RPA70A by a 70 residue linker, which in turn is connected to                  
*This chapter has been published:  Pretto D.I., Tsutakawa S., Brosey C.A., Castillo A., Chagot M.E., Smith J.A., 
Tainer J.A., Chazin W.J.  Structural dynamics and ssDNA binding activity of the three N-terminal domains of the 
large subunit of Replication Protein A from small angle X-ray scattering. Biochemistry. 2010 Apr 6;49(13):2880-9 
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RPA70B by a 10-residue linker. RPA70B is connected to RPA70C by a 15-residue linker. The 
RPA32 subunit contains a 45-residue unstructured N-terminal domain (RPA32N), along with a 
central OB-fold domain (RPA32D) and a C-terminal winged helix domain (RPA32C), which are 
separated by a 23-residue linker. The RPA14 subunit consists of a single OB-fold domain. High-
resolution structures have been determined by X-ray crystallography or NMR spectroscopy for 
all of the globular domains [11-14, 26, 42, 45, 105]. However, knowledge of the spatial 
organization of the domains in the intact protein is lacking [2]. Such information is important 
because remodeling of RPA “architecture” constitutes an essential element of its function in 
DNA processing machinery.  
 RPA ssDNA binding activity is associated with the A−D domains of RPA70 and RPA32. 
The binding of ssDNA by RPA occurs with a 5′ → 3′ molecular polarity in the order A, B, C, 
and D [6, 106]. The directional binding to ssDNA is the result of differences in the binding 
affinity of the four ssDNA binding domains. The RPA70A and RPA70B domains have the 
highest ssDNA affinity and serve as the anchor for all ssDNA binding activities. Two X-ray 
 
Figure 2.1.  Domain organization of RPA.  Rectangles are OB-fold domains, and the ellipsoid is 
a winged helix domain.  RPA32 has one unstructured N-terminal domain (RPA32N). 
Trimerization occurs via non-covalent interactions between RPA70C, RPA32D and RPA14 
domains.  ssDNA binds to RPA70A, RPA70B, RPA70C and RPA32D. 
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crystal structures of RPA70AB have been determined, one without ssDNA [11] and another in 
the presence of d-CCCCCCCC [45]. In the complex with ssDNA, RPA70A and RPA70B are 
aligned with the two binding loops wrapped around and nearly encircling the DNA. In contrast, 
two very different orientations of RPA70A with respect to RPA70B were observed in the 
structure of the free protein. Moreover, NMR analysis indicated the two domains of RPA70AB 
are structurally independent and implied that the two domains are attached by a flexible 
tether [7]. However, no direct information about interdomain orientations in solution and the 
effect of ssDNA on RPA70AB and the relationship with the rest of the protein has been 
obtained. 
 RPA70N is suggested to have weak ssDNA binding activity that is important for the 
DNA unwinding activity of RPA [3, 44]. However, the ssDNA binding affinity of this domain is 
more than 1000-fold weaker than that of RPA70AB, and RPA70N is generally accepted to be a 
protein interaction module targeting DNA replication, damage response and repair proteins such 
as p53 and ATRIP [32, 39, 41]. The only RPA70N structure is of the isolated domain [32, 42], so 
there is no available information about its disposition with respect to the rest of RPA and hence 
its availability to influence the DNA binding properties of the protein. NMR spectroscopy of a 
construct containing RPA70N, RPA70A, and a portion of RPA70B suggested that RPA70N does 
not interact with the RPA70A domain [43]. An NMR study of full-length RPA and larger 
multidomain constructs suggests the motion of RPA70N is independent of the remaining DNA-
binding domains, both in the absence and in the presence of ssDNA [4]. 
 To expand these initial observations and obtain direct information about interdomain 
orientation, we have turned to small angle X-ray scattering (SAXS), which is a powerful 
approach to studying proteins under native solution conditions and extracting low-resolution 
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spatial information for dynamic systems such as RPA. To experimentally address the structural 
dynamics of the RPA70A, RPA70B, and RPA70N domains, the impact of ssDNA binding on 
interdomain flexibility, and the effect of RPA70N on the ssDNA binding activity of the tandem 
high-affinity RPA70AB domains, we purified RPA70AB and RPA70NAB and examined them 
with and without ssDNA in solution by small angle X-ray scattering (SAXS). Analysis of SAXS 
data for these dynamic systems was facilitated by the generation of large ensembles of structures 
with different interdomain orientations using rigid body molecular dynamics simulations. The 
results show RPA70N is flexibly linked to RPA70AB and has no influence on the binding of 
ssDNA and have general implications for RPA dynamic architecture and functions. 
 
Results 
 To characterize the effects on the structural dynamics of RPA70A and RPA70B as they 
bind ssDNA and investigate the influence of RPA70N, small angle X-ray scattering (SAXS) 
experiments were performed on RPA70AB and RPA70NAB in the absence and presence of 
ssDNA. SAXS measures the electron pair distribution and is well-suited for characterization of 
the architecture of molecules in solution [107]. Since scattering data are distorted by scattering 
from small amounts of aggregation, the monodispersity of the samples was carefully monitored 
by multi-angle light scattering (MALS) of the peaks eluted during size exclusion 
chromatography (SEC) (Figures 2.2 and 2.3) and by verification of the data in the Guinier 
analysis.  To ensure monodispersity and remove any free DNA for protein−DNA complexes, 
each sample was treated by SEC just prior to the collection of data. 
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Figure 2.2.  TSK-gel G200sw elution profiles of (a) RPA70AB SEC-MALS experiments prior 
to SAXS data collection and (b) RPA70NAB SEC-MALS experiments prior to SAXS data 
collection, and (c) the corresponding calculated and experimentally determined molecular 
weights.  
 
 
 
 
 
A. 
 
 
B. 
  
 
C. 
Molecular 
Weight 
(KDa) 
AB AB- 
8mer 
AB-
14mer 
NAB NAB-
8mer 
NAB-
14mer 
Expected 27.2 29.6 31.4 46.1 48.5 50.3 
Calculated 27.9 27.5 30.0 40.9 41.3 45.6 
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Figure 2.3.  Superdex 200 SEC elution profiles for (a) RPA70AB and (b) RPA70NAB prior to 
SAXS data collection.  All protein samples are monomers and the protein:ssDNA complexes are 
1:1 ratios.   Red= NAB or AB alone; Green = NAB or AB with 8-mer; Blue =  NAB or AB with 
14-mer.  Excess ssDNA peaks are observed centered around 20 mL.   
 
 
Structural Dynamics of RPA70AB from Analysis of SAXS 
 The RPA70AB scattering profile (Figure 2.4a) reveals the high quality of the SAXS data 
obtained after optimization of the sample and acquisition parameters. A Kratky analysis of the 
data is consistent with the two globular well-folded domains connected by a 10-residue linker 
(Figure2.4b). The use of the Kratky plot of SAXS data to detect flexibility in proteins is well-
established (see Figure 24 of ref [92]). A Guinier analysis provided a radius of gyration (Rg) of 
RPA70AB in solution of 25.6 Å. The data were also analyzed with GNOM to derive the 
probability distribution function P(r), which reflects the distribution of interatomic distances in 
the molecule (Figure 2.4c). The main peak in the P(r) function corresponds to scattering between 
atoms within the globular RPA70A and RPA70B domains, which are similar in shape and size.  
The shoulder at longer distances corresponds to scattering between atoms in one domain and 
atoms in the other. The maximum distance (Dmax) in the P(r) function is 100 Å, and the Rg value 
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derived from P(r) is 25.7 Å, consistent with the reciprocal space Rg derived directly from the 
scattering data (Table 2.1). 
 
 
Figure 2.4.  Scattering curves (a), kratky analysis (b) and P(r) functions (c) for RPA 70AB in 
absence (black) and presence (gray) of d-(CCACCCCC). 
 
 
 
 
 
Proteins 
 
AB 
 
AB- 
8mer 
 
AB-14mer 
 
NAB 
 
NAB-8mer 
 
NAB- 
14mer 
 
Rg (Å),   
Guinier 
Analysis 
 
25.6 + 0.2 
 
23.4 + 0.3 
 
24.4 + 0.3 
 
39.5 + 0.4 
 
37.4 + 0.3 
 
37.9 + 0.2 
 
Rg (Å),  
P(r) 
analysis 
 
25.7 + 0.1 
 
23.2 + 0.1 
 
24.7 + 0.1 
 
43.7 + 0.2 
 
42.1 + 0.2 
 
41.6 + 0.2 
 
Dmax (Å), 
P(r) 
analysis 
 
100 
 
87 
 
100 
 
165 
 
165 
 
165 
 
Table 2.1.  SAXS measurements. 
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Figure 2.5.  CRYSOL fit to experimental data for each of the crystal structure models and their 
average.  Comparison of RPA70AB experimental SAXS scattering curves (black) and back-
calculated scattering curves (gray) for models 1 (a), 2 (b), 3 (c), and the average  (d).  Models 1 
and 2 correspond to the two molecules in the unit cell of  RPA70AB (1FGU.pdb).  Model 3 is 
the protein molecule after ssDNA atoms were extracted from RPA70AB/d-C8 (1JMC.pdb). 
 
 To examine the implications of the SAXS data for the solution structure, we back-
calculated scattering curves from three crystallographic models with CRYSOL and 
superimposed them on the experimental data (Figure 2.5 a-c). Models 1 and 2 correspond to the 
two different molecules in the asymmetric unit of the RPA70AB X-ray crystal structure, which 
have very different orientations of the two domains. Model 3 was obtained from the X-ray 
crystal structure of RPA70AB bound to d-CCCCCCCC, from which the ssDNA coordinates 
were removed. The χ2parameter reflecting the fit of the calculated curve to the experimental data 
is also included for each model. Although χ2 is dependent in part on the experimental noise, a 
lower χ2 value generally corresponds to a better fit of the model(s) to the experimental data. This 
analysis shows that although model 1 provides a better fit than the two other models, none of the 
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models fit especially well to the data. Similarly, each of the crystallographic models poorly fit 
the ab initio envelope predicted from the scattering data, with model 1 being most similar. These 
results suggest two possibilities. (i) The structure is not accurately represented by any of these 
three specific models, or (ii) the two domains occupy multiple interdomain orientations. 
 To distinguish these two possibilities, we employed rigid body molecular dynamics 
simulations with BILBO-MD [97] to generate 6400 conformers with a wide range of 
interdomain orientations. For these calculations, the RPA70A and RPA70B domains were 
treated as rigid bodies and the linker between them was allowed to fully sample conformational 
space (Figure 2.6a ). The radius of gyration was allowed to vary between 20 and 40 Å. The shape 
of the distribution of data in this plot is a reflection of the RPA70AB structure. Despite there 
being small gaps in the plot due to incomplete sampling of the conformational space accessible 
to RPA70AB, the sampling is sufficient to draw conclusions about the fit to the experimental 
data.  The observation of a wide χ2 minimum around 4 implies the data cannot be properly 
represented by a single structure. 
 
 
Figure 2.6.  Plot of χ2 fit parameter versus radius of gyration for RPA70AB (a) and RPA70NAB 
(b) conformers generated by bilbomd.  The calculated scattering curve for each conformer was 
generated by CRYSOL. 
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 To analyze the ensemble of structures, we employed a genetic algorithm to determine if 
select groups of conformers can fit the data better than single conformers [97]. The best fits 
obtained taking two and three conformers provide χ2 values of 2.1 and 1.6, respectively, 
indicating that multiple conformers represent the data far better than any single conformer. 
Figure 2.5d shows the improved fit to the experimental RPA70AB scattering obtained for the 
combination of three RPA70AB conformers comprised of models 1, 2, and 3 described above. 
Overall, analyses of the SAXS data show directly that the two domains in RPA70AB are not 
fixed in space but rather occupy a range of interdomain orientations. 
 
ssDNA Binding to RPA70AB 
 To determine the effect of binding ssDNA on the structural dynamics of RPA70AB, the 
scattering measurements were repeated in the presence of d-CCACCCCC. Previous studies have 
established that RPA70AB binds oligomers of 8−10 nucleotides with an affinity in the high 
nanomolar range [7]. The tight binding affinity for ssDNA implies that a monodisperse 
protein−DNA complex can be prepared and characterized, and the monodispersity was 
confirmed by SEC-MALS (Figures 2.2 and 2.3). 
 When the scattering data analyzed in the same manner as for free RPA70AB are 
compared to those of the free protein, it is evident that binding of ssDNA significantly reduces 
the protein’s structural dynamics (Figure 2.4a). The Rg value derived directly from the Guinier 
analysis was 23.4 Å, 2.2 Å shorter than the value determined for the free protein (Table 2.1). The 
range of interatomic distances reflected in the P(r) function is significantly decreased relative to 
that of the free protein (Figure 2.4c). In addition, the Dmax value is 87 Å, a reduction of 13 Å 
relative to that determined for the free protein. Notably, the Dmax is significantly larger than  
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Figure 2.7.  CRYSOL fit to experimental RPA70AB-8mer data (black) for the crystal structure 
model of RPA70AB bound to dC8 (gray).  Comparison of experimental scattering curve for the 
RPA70AB-8mer complex (black), versus the back-calculated scattering curve for the crystal 
structure (1JMC).  
 
the Dmax of 67.4 Å measured directly from the crystal structure (PDB entry 1JMC), even when 
the missing residues at the N- and C-termini are taken into account. The lower value of Rg and 
the narrowing of the curve and lower Dmax in the P(r) function all indicate there is an overall 
compaction of RPA70AB upon binding ssDNA [5]. The reduction in Rg in particular directly 
reflects the fact that the two domains are on average closer to each other when ssDNA is bound. 
This interpretation is consistent with the ssDNA serving to further tether the two domains 
together [7]. The SAXS data show directly that interdomain dynamics is quenched relative to 
free RPA70AB. 
 We next asked if the dynamic architecture revealed by the solution scattering data was 
accurately represented by the X-ray crystal structure of RPA70AB in complex with d-
CCCCCCCC. Gasbor calculations were first performed to determine the conformational 
envelope generated from the data. While the fits to the crystal structure were reasonable in this 
case, back-calculation provides a more direct and quantifiable assessment of the fits to atomic-
resolution models. We therefore turned to back-calculating the scattering curve from the 
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coordinates of the crystal structure using CRYSOL, and the results were plotted and compared to 
the experimental data (Figure 2.7).  
 Overall, there is agreement between the experimental scatter and the crystal structure, 
which is consistent with the value of 20.0 Å for Rg calculated from the crystal structure. 
However, the χ2 fitting parameter is 6.22, which indicates inconsistencies between the X-ray 
crystal structure and the SAXS data. This result suggests either the complex has a different 
structure in solution or, as for free RPA70AB, the complex cannot be adequately represented by 
a single structure. The latter explanation is supported by the observation in the Kratky analysis 
that the curve does not completely return to the baseline at higher scattering angles, which 
indicates that some disorder or flexibility is still present even when DNA is bound (Figure 2.4b). 
The interdomain flexibility probably arises from the flexible linker between domains and from 
torsional interdomain motions around the bound ssDNA and suggests the RPA70AB complex 
retains conformational flexibility that is not evident in the crystal structure. However, because of 
the low resolution of SAXS data, we cannot completely rule out the possibility that the complex 
can be represented by a single structure that is different from the crystal structure. 
 
Small Angle X-ray Scattering of RPA70NAB 
 To examine the structural dynamics of RPA70AB and investigate the influence of 
RPA70N, SAXS data were acquired for the RPA70NAB construct (Figure 2.8). An Rg value of 
39.5 Å was derived directly from the data based on the Guinier analysis, which is >14 Å greater 
than the Rg for RPA70AB. The P(r) function shows the same primary peak centered at 24 Å as 
observed for RPA70AB, reflecting scattering within the globular OB-fold domains (Figure 2.8c).  
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Figure 2.8.  Comparison of Scattering curves (a), kratky analysis (b), and P(r) function (c) for 
RPA70NAB in absence (black) and presence (dark and light gray, respectively) of d-
(CCACCCCC) and d-(AAAAAACCACCCCC). 
 
 The scattering curves differ substantially at longer distances. For example, Dmax extends 
out to 165 Å. Calculation of ab initio molecular envelopes directly from the scattering data using 
GASBOR did not converge. This observation suggests that envelope representations are 
problematic for highly flexible systems in which domain orientations may vary considerably 
between conformers. Together, the results from the SAXS analysis indicate that the 
conformational space sampled by RPA70NAB is substantially larger than that observed for 
RPA70AB. 
 To test the implications of the SAXS data with respect to the structural dynamics of 
RPA70NAB, BILBO-MD was used to generate 6000 conformers of RPA70NAB. For these 
calculations, each globular domain was treated as an independent rigid body, but the N−A and 
A−B linkers were allowed to sample conformational space freely (Figure 2.6 b).  Notably, 
χ2 does not reach a specific minimum but rather reaches a plateau through a wide range 
of Rg values, even more so than what was observed for RPA70AB. This observation of a broad 
plateau for the χ2 minimum indicates the data are not properly represented by a single structure 
and suggests that RPA70NAB has substantial interdomain flexibility. 
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 To obtain further insight into the solution structure of RPA70NAB, we examined 
representative conformers from the ensemble generated by BILBO-MD, including fully extended 
and closely packed arrangements of the three domains. CRYSOL was used to back-calculate 
scattering curves for each conformer selected (Figure 2.9). The calculated Rg values are 45 Å 
for the extended conformation and 29 Å for the closely packed conformation. The Rg value for 
both of these conformers is far from the experimentally observed value, and the scattering curves 
do not match the experimental data. Notably, poor fits to the scattering curve were also obtained 
even for specific conformers that closely match the experimentally observed Rg value. Thus, the 
SAXS data indicate that RPA70NAB has extensive interdomain flexibility, which is substantially 
larger than RPA70AB as a result of the long flexible linker between the N and A domains. 
 
Effect of ssDNA Binding on the Structural Dynamics of RPA70NAB 
 To investigate the effects of binding ssDNA on the structural dynamics of RPA70NAB, 
we performed experiments with an 8mer and a 14mer ssDNA oligonucleotide. The 8mer 
corresponds to the excluded site size of RPA70AB and is designed as a control to characterize 
the effect of ssDNA binding to these high-affinity domains. The 14mer was designed to 
determine if RPA70N is able to modulate the ssDNA binding activity by providing six extra 
nucleotides to the 5′ side of the high-affinity RPA70AB domains. The SAXS experiment is 
ideally suited to detect ssDNA binding by RPA70N in the context of RPA70NAB because any 
appreciable interaction would produce a pronounced compaction of the molecule as a result of 
the alignment of RPA70N with RPA70AB. In particular, since RPA70AB is already strongly 
bound to eight nucleotides of ssDNA, the binding of RPA70N to the remaining overhang would 
result in a substantial reduction in the Rg of RPA70NAB to a value in the vicinity of 30 Å. 
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 Two important considerations guided the design of the 14mer oligonucleotide used for 
these experiments. (i) The number of nucleotides had to allow binding of an additional OB-fold 
domain without enabling binding of a second molecule, and (ii) the position of RPA70AB on the 
ssDNA needed to be biased to the 3′ end of the oligo to maximize the availability of free ssDNA 
for binding to RPA70N. The X-ray crystal structure of RPA70AB bound to d-CCCCCCCC 
shows each OB-fold domain makes contact with three nucleotides, and two nucleotides bridge 
the RPA70A and RPA70B domains [45]. Thus, the length of the oligonucleotide needed to be 
fewer than 16 nucleotides to preclude binding of two protein molecules on the DNA. A ssDNA 
14mer was therefore selected because it is too short for binding two molecules yet provides six 
extra nucleotides for RPA70N to bind. The d-CCACCCCC sequence was used at the 3′ end of 
the 14mer oligonucleotide on the basis of previous analysis of the sequence preferences of 
RPA70AB (E. Bochkareva, A. I. Arunkumar, W. J. Chazin, and A. Bochkarev, unpublished 
results). These studies showed that RPA70AB binds more strongly to cytosine rich sequences 
than adenine rich sequences and that placement of a single adenine at position 3 in d-
CCCCCCCC further enhances binding affinity. To bias RPA70AB to the 3′ end of the 
oligonucleotide, the 14mer was constructed by adding six adenines to the 5′ side of the high-
affinity sequence, resulting in d-AAAAAACCACCCCC. Although RPA binds polyadenine 
more weakly than polypyrimidines, the affinity is nonetheless in the nanomolar range [8]. 
Moreover, six free adenines is adequate for binding because the tethering to RPA70AB means 
RPA70N is present in a higher local concentration relative to that for free diffusion. All studies 
with 8mer oligonucleotides used the sequence d-CCACCCCC to ensure the accuracy of the 
comparisons between binding of RPA70NAB to 8mer and 14mer ssDNA. 
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Figure 2.9.  Comparison of experimental scattering curves for RPA70NAB (black) against back-
calculated scattering curves of selected BILBOMD generated models (gray).  Cartoon 
representations are shown for each of the models, along with the corresponding χ2 fit parameter 
and Rg values. 
 
 
 Scattering measurements for RPA70NAB bound to d-CCACCCCC (8mer) or d-
AAAAAACCACCCCC (14mer) were taken and analyzed following the strategy for the free 
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protein and the RPA70AB−ssDNA complex. Comparison of the data with free RPA70NAB 
reveals that binding of ssDNA alters the structural dynamics of the protein, although in a relative 
sense, the effect on the scattering curve is not as great as for RPA70AB (Figure 2.8a). A Kratky 
analysis indicated little change in the relative amount of unordered polypeptide in RPA70NAB 
when either ssDNA oligomer was bound (Figure 2.8b). The Rg values from the Guinier analysis 
for the 8mer and 14mer are 37.4 and 37.8 Å, respectively, reflecting a reduction of 2.1 and 1.7 Å, 
respectively, relative to that of the free protein. As was observed for RPA70AB, the peak range 
of interatomic distances reflected in the P(r) function decreases significantly (Figure 2.8c). These 
observations indicate reductions in Rg and Dmax upon binding of ssDNA closely parallel what is 
observed for RPA70AB. Thus, the data indicate a compaction of the RPA70AB domains as they 
bind the ssDNA within the complex, which is correlated with quenching of the interdomain 
dynamics of these domains. However, there is no indication of further compaction of the protein, 
which would result from the RPA70N domain also engaging the ssDNA. On the contrary, the 
SAXS data show that RPA70N remains as flexible in the DNA-bound state as in the free protein, 
confirming the hypothesis proposed on the basis of indirect NMR evidence in our study of intact 
RPA [4]. 
 To further analyze the data, large ensembles of conformations for both 
RPA70NAB−ssDNA complexes were generated using BILBO-MD, and then the scattering was 
back-calculated using CRYSOL and compared to the experimental data. The initial model was 
built using the coordinates from the X-ray crystal structures of RPA70N and RPA70AB bound to 
d-CCCCCCCC, along with a purely modeled N−A linker. For these calculations, the entire 
RPA70AB module was treated as a single rigid body, RPA70N was treated as a second rigid 
body, and the N−A linker was allowed to sample conformational space freely. For a select 
62 
 
number of conformers, 14mer ssDNA was added back and CRYSOL was used to back-calculate 
scattering profiles. An examination of a range of different conformers, including highly extended 
and closely packed arrangements of the three domains, shows that, in fact, scattering is 
dominated by the relative position of the three globular domains (Figure 2.10).  
 The key to our interpretation is the fact that all of the observed Rg values for RPA70NAB 
experiments (Table 2.1) are consistent only with RPA70N populating interdomain orientations 
 
 
Figure 2.10.  Models of RPA70NAB in the presence of the ssDNA 14-mer.   The complex with 
with Rg = 29 was generated by manually positioning the RPA70N domain in a position that 
mimics ssDNA binding.  All other conformers were generated using BILBO-MD as indicated in 
the Methods section. 
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where it is distant from RPA70AB. In particular, in experiments with the 14mer, if RPA70N 
were interacting with the ssDNA it would be closely packed to RPA70AB and the overall shape 
of the RPA70NAB molecule would be substantially more compact and globular (Figure 2.9). 
This would result in Rg values significantly lower than those observed in the control experiments 
with the free protein and the 8mer ssDNA. The models of the complex of RPA70NAB with the 
14mer in which RPA70N is packed near the DNA have Rg values on the order of 29 Å, which is 
far from the experimentally determined value of 41 Å. Thus, our analysis shows that RPA70N 
does not become ordered even when ssDNA is bound to RPA70NAB. 
 
Discussion 
 RPA ssDNA binding occurs with 5′ to 3′ directionality, initiated by high-affinity ssDNA 
binding domain RPA70A [6, 106, 108]. The existence of the short 10-residue A−B linker 
increases the effective concentration of RPA70B, which promotes its binding to ssDNA [7]. 
Binding of DNA to RPA70AB is followed in turn by rearrangement of RPA70C and RPA32D. 
The trajectory of binding is therefore in opposition to the orientation of RPA70N toward the 5′ 
end of ssDNA sequences. 
 It has been proposed that RPA70N plays a direct role in binding ssDNA [3, 44]. The 
ssDNA binding affinity for the isolated RPA70N domain is extremely weak, which on the basis 
of the evidence in the literature [32, 43, 44] has a lower limit for the dissociation constant (Kd) in 
the millimolar range. Our study was designed to determine the effect of RPA70N in the context 
of ssDNA binding to the adjacent RPA70 A and B domains, which more directly addresses the 
hypothesis put forth in the literature. The effective local concentration of ssDNA in the vicinity 
of RPA70N is maximized in the experiment with the ssDNA 14mer, therefore providing every 
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opportunity for the RPA70N domain to engage the ssDNA. If RPA70N had any role to play at all 
in binding ssDNA, this would have been reflected in a change in the distribution of 
conformational states occupied by RPA70NAB relative to the distributions observed in the 
control experiments on free RPA70NAB and the complex with the ssDNA 8mer. The fact that 
there is no indication of interaction of RPA70N with ssDNA in the context of RPA70NAB is 
convincing evidence against the proposal that RPA70N plays a direct role in the ssDNA binding 
activity of RPA. 
 The 70-residue linker between the N and A domains suggests there would be little 
correlated movement of the two domains, as suggested by NMR relaxation analysis of a 
construct containing RPA70N, RPA70A, and a portion of RPA70B [43]. However, it is difficult 
to draw firm conclusions from that study because the RPA70A domain in the absence of the 
RPA70B domain has only very weak affinity for ssDNA. Our studies show directly, and in the 
physiologically relevant context of high-affinity binding of ssDNA, that the dynamic and flexible 
N−A linker enables a wide range of RPA70N orientations relative to RPA70AB. Thus, the long 
linker provides the large degree of freedom to RPA70N that is critical to this domain’s 
participation in the recruitment of partner proteins. RPA70N binds multiple proteins involved in 
DNA replication, damage response, and repair mechanisms, including p53, ATRIP, MRE11, and 
NBS1[32, 39-41]. Hence, our results support models of RPA function in which RPA70N acts as 
a general protein recruitment module. 
 SAXS is an emerging technique in structural biology that measures electron scattering 
intensities to yield interatomic distances for molecules in solution [92, 107]. For globular 
proteins, which have fixed rather than variable conformations, it is possible to convert this 
distance distribution into molecular envelopes that reflect the average shape of a protein or 
65 
 
protein complex in solution [92]. Such coarse-grained structural envelopes are invaluable 
complements to atomic-resolution information. For systems with high degrees of interdomain 
flexibility, such as RPA70NAB, a single, “averaged” conformation fails to provide an adequate 
description of an intrinsically time-varying architecture. The lack of statistically significant 
correlation reflected by high χ2 values between experimental scattering profiles from 
RPA70NAB and those calculated for individual models readily illustrates this point and defines 
this as a flexible region. Proper interpretation of scattering data from these flexible systems 
requires an ensemble approach, both to describing the population of feasible conformations and 
to characterizing their relative frequency within the ensemble at a given moment in time. 
BILBO-MD [97] allowed us to search a broad range of accessible RPA70NAB conformational 
space and examine in detail a subset of models (including some that represent the extreme 
conformations) and their capacity to recapitulate the scattering data. Notably, while averaging 
theoretical scattering profiles from multiple conformations improves the goodness of fit to the 
experimental data, the challenge of distinguishing the relative merit of one conformational subset 
over another remains. 
 Methods and programs are available to select combinations of conformers that provide 
better fits to the data, including the minimum ensemble (MES) approach that is part of BILBO-
MD [97]. However, while it is possible to define combinations of structures that give improved 
fits to the data, these combinations are not necessarily unique but represent a minimal identified 
ensemble that fits the data. In the case of highly flexible proteins, there are many combinations 
of conformers that fit the data equally well. Consequently, the main conclusion that can be drawn 
from this type of analysis of a complex highly flexible system such as RPA70NAB is that the 
protein contains substantial degrees of conformational heterogeneity, a point that is best made 
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directly from data. Nevertheless, ensemble fitting does provide valuable insight into the 
dynamics of the native, solution architectures of proteins and macromolecular complexes. 
 The key role of dynamics in facilitating the organization and progression of large 
multiprotein machines is increasingly recognized particularly for DNA replication and repair 
machinery that requires precise coordination to efficiently preserve genome integrity. Our results 
suggest SAXS offers a robust approach to characterizing protein structural dynamics in solution 
without the complications of isotopic enrichment or spin labeling required by spectroscopic 
methods. RPA70N is found to be structurally independent of RPA70AB in the DNA-bound state 
and therefore able to act flexibly as a protein recruitment module. Notably, this flexible 
attachment of the RPA DNA and protein binding domains, elucidated by SAXS, enables the 
interactions of RPA with diverse DNA substrates and protein partners required for effective 
orchestration of DNA replication and repair. Similar flexible attachments joining protein and 
DNA binding domains were recently discovered for DNA-PK and polynucleotide kinase [109, 
110]. In fact, such RPA domain structural flexibility as experimentally defined here is essential 
to allow efficient protein handoffs and interface exchanges, as proposed for FEN1-
PCNA [111] and BRCA2-Rad51[112]. RPA binding protein partners, such as the 
Mre11−Rad50−Nbs1 complex, have similar ordered and flexible domains, as shown by Nbs1 
SAXS and crystal structures [113]. Such dynamic character may be a hallmark for scaffold 
proteins such as RPA. 
 The role of dynamics in facilitating recruitment, organization, and exchange of DNA 
processing factors has been characterized in several model systems, most notably in a recent 
study of homotetrameric E. coli SSB diffusion dynamics along ssDNA [114]. In that study, SSB 
diffusion was shown to be critical for resolving DNA secondary structures to enable RecA 
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filament formation. Unlike the modular, multidomain RPA, the homotetrameric single-domain 
SSB does not utilize preexisting structural dynamics to facilitate organizing strands of ssDNA 
for DNA processing. Instead, the compact, globular SSB homotetramer is encircled by the 
ssDNA and is thought to “roll” along the template via a consecutive unwrapping and wrapping 
of ssDNA. Thus, while the structural organization of these two SSB systems remains 
fundamentally different, dynamic motion would appear to be integral aspects of both. 
Specifically, the nature of the structural dynamics of linked, ordered, and flexible RPA domains 
as identified here appears to be critical to the accommodation of the large-scale complex 
conformational changes proposed to regulate RPA-related functions, while preserving the 
integrity of DNA and protein partner interactions for maintaining genetic fidelity. 
 
Experimental Procedures 
Expression of RPAs 
 Fragments of human RPA were expressed from a pSV281 RPA70AB plasmid containing 
a TEV cleavable six-His tag at the N-terminus and a pBG100 RPA70NAB plasmid containing an 
H3C six-His tag also at the N-terminus. TEV and H3C proteases are produced in-house. ssDNA 
oligomers d(CCACCCCC) and d(AAAAAACCACCCCC) purchased from Integrated DNA 
Technologies were desalted, lyophilized, and resuspended into autoclaved distilled water. 
 Recombinant RPA70AB (RPA70181−422) and RPA70NAB (RPA701−422) constructs were 
prepared as described previously [4, 7]. Proteins were expressed in Escherichia coli host Rosetta 
(DE3) cells (Novagen, Madison, WI). Cells were grown in LB medium containing kanamycin at 
37 °C, induced with 0.1 M IPTG when the OD reached 0.6, and harvested after 3 h using a JLA 
8.1 Beckman rotor at 7500 rpm and 4 °C. Pellets were stored at −20 °C. 
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Protein Purification 
 RPA70AB samples were purified using nickel-nitrilotriacetic acid resin (NiNTA) by 
nickel affinity chromatography in 10 mM Hepes (pH 7.5), 500 mM NaCl, 5 mM BME, and 10% 
glycerol using an elution gradient from 20 to 300 mM imidazole. Cleavage of the His tag with 
TEV protease was performed through overnight dialysis in a buffer containing 10 mM Hepes 
(pH 7.5), 200 mM NaCl, 5 mM BME, 200 mM L-arginine, and 10% glycerol. A second NiNTA 
purification step was used to remove the His tag. Size exclusion chromatography (SEC) using a 
Superdex S75 column equilibrated with the dialysis buffer was used as a last step of purification. 
Protein was concentrated, and stock solutions were frozen in a dry ice/ethanol bath and kept at 
−80 °C. The same procedure was used for RPA70NAB samples using NiNTA buffer [30 mM 
MES (pH 6.5), 500 mM NaCl, 10 mM BME, and 5 mM MgCl2] and cleaving with H3C protease. 
The SEC step was performed using a Superdex S200 column and a buffer containing 30 mM 
MES (pH 6.5), 200 mM NaCl, 10 mM BME, 10% glycerol, and 5 mM MgCl2. 
 
Preparation of Protein−DNA Complexes 
 RPA70AB or RPA70NAB was incubated in the presence of a 1.2−1.5-fold molar excess 
of d(CCACCCCC) or d(AAAAAACCACCCCC) for 20 min on ice; 500 μL of sample was 
purified by SEC using S75 (RPA70AB) or S200 (RPA70NAB) resin. The samples eluted as one 
peak for the complex followed by a DNA-only peak. 
 
Size Exclusion Chromatography via Multi-Angle Light Scattering 
 The monodispersity of each sample was verified by multi-angle light scattering 
connected in line with SEC (SEC-MALS). All experiments were performed using a Wyatt 
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Technology instrument, and data were analyzed using ASTRA version 16.25. Samples were 
analyzed using a 2.4 mL Superdex75 column. Only samples that exhibited monodispersity were 
selected for data collection. 
 
Small Angle X-ray Scattering 
 SAXS data of the various RPA constructs were collected at the SIBYLS 12.3.1 beam line 
at the Advanced Light Source, Lawrence Berkeley National Laboratory. Scattering 
measurements were performed on 20 μL samples at 15 °C using a Hamilton robot for loading 
samples from a 96-well plate into a helium-purged sample chamber. Protein−DNA samples were 
further purified on a 24 mL SEC column just prior to data collection to eliminate any free protein 
or DNA. Data were collected on both the original gel filtration fractions and samples 
concentrated 2−8-fold from individual fractions. Fractions prior to the void volume and 
concentrator eluates were used for buffer subtraction. 
 The experiments with RPA70AB used an X-ray beam from a single-crystal 
monochomator of 11 keV, covering the following momentum transfer range: 0.007 Å
−1
 < q < 
0.35 Å
−1
 (q = 4π sin Θ/λ, where 2Θ is the scattering angle). Sequential exposures (6, 6, 60, 6, 
200, and 6 s) were taken, and data were monitored for radiation-dependent aggregation. SAXS 
experiments for all RPA70NAB samples and for RPA70AB with DNA were acquired using an 
X-ray beam from a multilayer monochromator of 12 keV covering the following momentum 
transfer range: 0.012 Å
−1
< q < 0.317 Å
−1
. The multilayer provides increased X-ray flux allowing 
stronger signals for lower protein concentrations. Sequential exposures (0.5, 0.5, 5, and 0.5 s) 
were taken, and data were monitored for radiation-dependent aggregation. All SAXS data were 
collected using the MarCCD 165 detector in fast frame transfer mode and reduced via 
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normalization to the incident beam intensity. Buffer scattering was subtracted from protein 
scattering. This was followed by azimuthal averaging to obtain the intensity I(q) 
versus q scattering plot visualized by xmgrace. The data were analyzed using PRIMUS (Primary 
Analysis & Manipulations with Small Angle Scattering Data) version 3.0 from ATSAS 
2.0 [115], from which Guinier, Kratky, P(r), and CRYSOL plots were generated. 
 For each sample, multiple experiments were conducted over multiple runs. Experiments 
providing the highest signal-to-noise ratio that remained consistent with the relative 
concentrations from original gel filtration fractions were selected for further analysis. For 
RPA70AB alone, the final data used for analysis were merged between a 60 s exposure at 147 
μM and a 200 s exposure at 331 μM. The concentrations of the samples used for analysis for 
RPA70AB with 8mer DNA, RPA70AB with 14mer DNA, RPA70NAB alone, RPA70NAB with 
8mer DNA, and RPA70NAB with 14mer DNA were 71, 81, 163, 80, and 98 μM, respectively, 
each with a 5 s exposure time. 
 
Computational Modeling 
 Ab initio shape envelopes were calculated with GASBOR [94]. Ten GASBOR runs were 
merged using the DAMAVER suite. Protein Data Bank (PDB) coordinates were overlaid using 
SUPCOMB. PDB coordinates from the RPA70N NMR structure (entry 1EWI) and the 
RPA70AB ssDNA-bound X-ray crystal structure (entry 1JMC) were used to construct a model 
for RPA70NAB. From these coordinates, multiple conformers were generated by rigid body 
molecular dynamics simulations with BILBO-MD [97]. For the DNA complexes, ssDNA 
coordinates were removed from the RPA70AB model. For RPA70NAB, the connecting linker 
between domains 70N and 70A was built using the Biopolymer module of Insight II (Accelrys, 
Inc., San Diego, CA), followed by refinement with Rosetta [116]. To generate 
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RPA70NAB−ssDNA complexes for back-calculation of scattering profiles, the DNA coordinates 
were added back using Molecular Operating Environment, MOE 2010.09 (Chemical Computing 
Group, Montreal, QC) and Chimera [117]. Molecular graphics were generated using PyMol 
(DeLano Scientific, Palo Alto, CA). 
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CHAPTER III 
 
TOWARD STRUCTURAL CHARACTERIZATION OF THE 
HYPERPHOSPHORYLATED FORM OF RPA 
 
Introduction 
 Studies have shown that RPA phosphorylation results in decreased binding of RPA to 
DNA pol-α, DNA-PK and ATM, suggesting that these interactions are modulated by RPA’s 
phosphorylation state [60].  It can be hypothesized that this corresponds to a type of negative 
control mechanism to regulate RPA’s functions in which the kinases that phosphorylate RPA 
have a higher affinity to unphosphorylated substrate than to the more electronegative product, 
consistent with studies showing weaker affinity of RPA kinases for the phosphorylated RPA 
[60].  Similarly, it has been suggested that the effect of phosphorylation on the interaction with 
DNA pol-α may be to aide in the release of DNA pol-α from the replication initiation site (see 
review [104]).  
 Scanning transmission electron microscopy (STEM) studies aimed at understanding 
RPA-DNA binding and its role in heterologous interactions suggest that RPA can occupy an 
elongated conformation when is bound to a 30 nt ssDNA, and a closely packed conformation 
when bound to an 8 nt ssDNA [118].   These structural states were detected in the presence of 
long ssDNA depending on the concentration of RPA used and the use of cross-linking reagent.  
RPA phosphorylation  was found to be inversely proportional to the number of RPA molecules 
bound to the ssDNA [118].   Notably, RPA was bound to DNA prior to in-vitro phosphorylation 
by DNA-PK.  This means that when RPA was bound to 30 nt it became more easily 
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phosphorylated than when it was bound to 8 nt of ssDNA. These results can be interpreted in 
light of what could be happening to RPA32N, the flexible region that contains the 
phosphorylation sites in RPA32.  In 
15
N-
1
H HSQC NMR experiments on the full-length RPA 
heterotrimer performed by our group, chemical shifts that belong to the RPA32N glycine 
residues are perturbed and have better correspondence to the chemical shifts of free RPA32N(1-
46) peptide when dT30 is added [4].  This is consistent with the flexible RPA32N becoming more 
free or mobile in the DNA bound form of RPA.  It has been suggested that DNA binding is a 
pre-requisite to RPA phosphorylation [53].  Together these data suggests that RPA32N may be 
more accessible to the various RPA kinases when RPA is bound to ssDNA in its most elongated 
form.   
 The STEM studies do not have sufficient resolution to indicate where RPA32N and other 
specific domains are located and how these might differ in the non-phosphorylated and 
phosphorylated states.  Additional insights can be drawn based on the crystal structure of the 
minitrimer core (RPA70C/32D/14).  Although RPA32N is not present in the trimeric core, the 
direction of the backbone at amino acid 45 orients RPA32N in close proximity to RPA70C, 
roughly pointing towards Phe532 and Tyr581 (Figure 3.1).  These residues form a cleft that is 20 
Å away from Ile46 (Figure 3.1b). Strikingly, the DNA-binding cleft of 32D is also ~20 Å from 
Ile46 [12] (Figure 3.1c).  Thus, structural data suggests that RPA32N might interact with 
RPA70C and/or RPA32D.  It has been proposed that such interactions could regulate the DNA 
binding activity of the core [14].    
 Given the possibility that RPA32N may interact with domains in the trimer core, it is of 
interest to consider whether or not phosphorylated RPA32N interacts differently with other 
domains of RPA.  A previous report from the Wold laboratory demonstrated a direct interaction  
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Figure 3.1.  RPA minitrimer core.  Direction of the backbone at RPA32 amino acid 45 orients 
RPA32N in close proximity to RPA70C, roughly pointing towards Phe532 and Tyr581 (a).  
RPA32N Ile46 is ~20 Å away from the RPA32D (b) and RPA70C (c) basic clefts. 
 
using NMR between RPA70N and an RPA32N phospho-mimic synthetic peptide that contains 
all phosphorylatable residues (Ser8, Ser11, Ser12, Ser13, Thr 21, Ser23, Ser29, Ser33), except 
Ser4, mutated to aspartic acid [44].   
 Further evidence for intersubunit interactions was demonstrated in the intact RPA 
heterotrimer phosphorylated in-vitro with DNA-PK [119].  Lysine residues on the surface of the 
protein were biotinylated and the protein trypsin digested, then the peptide patterns analyzed by 
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SDS-PAGE and unique peptides identified by MALDI-TOFF and MS/MS mass spectrometry.  
Protection against trypsin digestion by biotin labels bound to the surface lysines in the non-
phosphorylated RPA would be expected on the hyperphosphorylated RPA, unless a 
conformational change or rearrangement may occur upon phosphorylation, in which case the 
protection pattern would change as some lysine residues may no longer be exposed at the surface 
and be protected from biotinylation, or new lysines would be exposed to the surface.  A 
comparison of peptide masses from non-phosphorylated and hyperphosphorylated RPA samples 
demonstrated a possible interaction between RPA70B and the hyperphosphorylated RPA32N, 
but not with 70N [119].  The authors argue that this is a more feasible scenario since RPA32N is 
in closer proximity to RPA70B than to 70N.  However, given the long length of the RPA70N 
linker and direct evidence for RPA70N interaction with the phospho-mimetic peptide shown by 
NMR [44], this assumption may not be accurate.  Moreover, this does not explain why the 
phosphorylated RPA32N would not interact with RPA70C or RPA32D which, according to the 
minitrimer core crystal structure, is even more accessible to RPA32N than RPA70B  [14].   
 The same study confirmed RPA70B binding to the phosphorylated RPA32N [119].  
Tryptophan fluorescence quenching experiments of a full-length RPA mutant construct in which 
all tryptophan residues, except RPA70B W361 and RPA70A W212, had been mutated to alanine 
was compared before and after in-vitro DNA-PK phosphorylation, demonstrating that 
hyperphosphorylation resulted in significant tryptophan fluorescence quenching.  The effect was 
attributed only to RPA70B since biotinylation experiments indicated that RPA70B was the most 
likely candidate for interaction with the phosphorylated RPA32N.   However this study cannot 
rule out the possibility that RPA70A could also contribute to the interaction with the 
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phosphorylated RPA32N peptide since the contribution from RPA70A W212 was not separated 
from RPA70B W362, and it did not address interactions with RPA70C or RPA32D. 
 In an effort to eliminate controversy and shed light into possible rearrangement of RPA 
structure induced by hyperphosphorylation of RPA32 that may lead to changes in RPA function, 
I have performed a systematic study of RPA32N interactions with other RPA domains.  A 
recombinant pseudo-phosphomimetic peptide, RPA32N-D8, designed with Ser →Asp mutations 
on Ser8, Ser11, Ser12, Ser13, Thr21, Ser23, Ser29, and Ser33 was used to mimic the 
hyperphosphorylation of RPA.  These mutations replicate the peptide conditions used in the 
previous NMR study focused solely on RPA70N [44] and those selected for in vivo studies 
showing localization of pseudo phosphorylated RPA32 to sites of DNA damage [68]. 
 
Results 
 
Production of recombinant RPA32N wild-type and phosphomimetic peptides 
  
 In order to characterize the RPA32N domain and putative changes that occur upon 
hyperphosphorylation of RPA32N, wild-type and mutant peptides were subcloned using existing 
plasmids from full-length RPA as templates.  We initially tried to build a 6X-His tagged pET15b 
construct of wild-type RPA32N that spanned only the 35 amino acids, RPA32N1-35 containing 
the minimal region of RPA32N phosphorylation.  However, although construction of the plasmid 
was successful, the peptide was either degraded during lysis or trapped into inclusion bodies, 
depending on the presence or absence of lysozyme in the lysis buffer, respectively.  In order to 
improve the prospect of isolating the peptide, 6X-His-MBP and 6X-HIS-SUMO RPA32N1-35 
recombinant peptides were generated using in house vectors, pLM102 and pBG102, respectively.  
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Protein at high expression levels was successfully purified using NiNTA affinity 
chromatography.  However, the peptide degraded immediately after cleavage of the affinity tags.    
Therefore, it was determined that the construct was unstable, and the fragment was extended to 
46 amino acids to include the linker region that connects the RPA32N flexible domain to the 
RPA32D central domain of RPA32 subunit.  Wild-type (RPA32Nwt) and mutant (RPA32N-D8) 
RPA32N1-46 constructs were successfully generated using pLM302 and pBG102 vectors.  
Expression of recombinant peptides from these constructs remained as high as before, and 
cleavage of the affinity tags by H3C protease did not result in degradation of the peptides (Figure 
3.2 and 3.3).    
 
 
Figure 3.2.  Purification of pBG102 RPA32Nwt 1-35 and RPA32Nwt1-46 peptides.  a). Nickel 
purification of the 35 amino acid fragment shows that degradation of the peptide has taken place 
during the purification as observed in the flow through and elution fractions containing mostly 
6X-His sumo tag.  Nickel purification of the 46 amino acid fragment shows this peptide is more 
stable.  Elution fractions contain mostly 6X-His-Sumo-peptide.  b). Cleavage reaction with H3C 
protease shows that only the 46 amino acid peptide can be recovered.    
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Figure 3.3.  Purification of pBG102 RPA32N-D8 peptide.  a). Nickel purification of the 46 
amino acid 6X-His-SUMO-RPA32N peptide containing aspartic acid mutations on Ser4, 8, 11, 
12, 13, 23, 29, 33 and Thr 21.   Partial cleavage is seen during the purification.   b).   H3C 
protease cleavage reaction shows good separation of the peptide which runs at ~10 KDa.  c).  
Dilute and concentrated peptide. 
 
 
 
Wild-type and phosphomimetic RPA32N peptides are unstructured 
 A combination of matrix-assisted laser desorption/ionization mass spectrometry 
(MALDI-MS) analysis, circular dychroism (CD) and nuclear magnetic resonance (NMR) 
spectroscopy was used to characterize the RPA32Nwt and RPA32N-D8 peptides.   Analysis of  
MALDI-MS spectra showed a single peak with 5087 m/z for RPA32Nwt, and a peak with 5338 
m/z for RPA32N-D8.  Although both peptides have the same number of residues, their difference 
in mass is consistent with the amino acid composition of the peptides.  Each Ser → Asp mutation 
generates a 28 g/mol difference in molecular mass, in addition to the 13.9 g/mol difference for 
one Thr → Asp mutation.  A single minimum observed at 200 nm in the far-UV CD spectrum 
for the RPA32Nwt indicated that the peptide lacks any helical or beta sheet character. In order to 
examine if the phosphomimic mutations elicit helical character formation, the same experiment 
was performed with the RPA32N-D8 peptide.  However, as observed with the wt peptide, a  
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Figure 3.4.  
15
N 
1
H HSQC spectra of RPA32N peptides.  a) 
15
N 
1
H RPA32Nwt spectrum is 
shown on the left.   b) The 
15
N 
1
H HSQC spectrum of RPA32N-D8 is shown on the right. A gel 
showing the NMR sample is shown to the left of each spectrum.   
 
single minimum at 200 mM in the far-UV spectrum indicates no secondary structure is formed.  
Conclusively, 
15
N- 
1
H HSQC NMR spectra of 
15
N-enriched RPA32Nwt and RPA32N-D8 show a 
lack of peak dispersion for both peptides, which is indicative of lack of tertiary structure or 
unfolding (Figure 3.4).  After optimization of NMR spectral conditions, which involved testing 
various buffers, temperature and pH conditions, a total of 30 peaks can be distinguished for the 
RPA32Nwt versus 43 peaks for RPA32N-D8 mutant.  
15N-1H RPA32Nwt
15N-1H RPA32ND8
a
b
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Isolated RPA70N, RPA70A and RPA70B Domains Interact With Phosphomimetic 
RPA32N  
As previously mentioned, 
15
N-
1
H HSQC NMR titration experiments indicate a weak interaction 
between RPA70N and a phosphomimetic RPA32N peptide [44]. This interaction has been 
mapped to the protein-protein interaction interface of RPA70N, involving residues Asn29, Ile30, 
Arg31, Tyr42, Leu44, Leu45, Ser55, Met57, His80, Arg92, Val93 and Val94.  However, mass 
spectrometry footprinting assays on full-length RPA hyperphosphorylated with DNA-PK only 
detected a protection on RPA70B domain residues Lys343, Arg335, and Arg382 [119].  These 
results lead to the conclusion that interaction with RPA70N was not likely to occur in the full-
length protein. However, this type of analysis presents certain restrictions as the read out 
mechanism involved protection of biotinylated lysine and arginine residues only, which represent 
only four of the identified RPA70N interacting residues.  In order to fully characterize RPA32N-
mediated intersubunit interactions a systematic approach was applied in an effort to accurately 
describe all interactions.  The observations from the above mentioned studies suggest that 
intersubunit interactions with RPA32N occur via electrostatic forces.  Given that the RPA70A 
domain has a more basic interacting region, it was possible that this domain also participates in 
interactions with RPA32N.   Thus, we begin our analysis with the high-affinity ssDNA binding 
domains RPA70AB. 
 A
 15
N-
1
H
 
HSQC spectrum was recorded for 
15
N-RPA70AB in buffer containing 10 mM 
HEPES at pH 7.5, 100 mM NaCl and 5 mM BME, and a second spectrum was collected upon 
addition of a 15X molar excess of RPA32N-D8 peptide.  NMR assignments for RPA70A and 
RPA70B were transferred to the RPA70AB spectrum, and chemical shift perturbations resulting 
from addition of the RPA32N-D8 peptide were mapped to the corresponding residues.  Chemical 
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shift changes that were above the average plus one standard deviation were considered 
significant chemical shift perturbations.  Residues Ser195, Ser213, Gly219, Arg234, Lys263, 
Asp301, Val334, Val341, Arg344, Arg382, Ser384, and Asp385 were perturbed  in the spectrum.  
These results were largely reproduced upon addition of RPA32N-D8 to the isolated 
15
N-
RPA70A and 
15
N-RPA70B domains.  Curiously, many more chemical shift perturbations were 
observed on the isolated domains, including for RPA70A residues Lys206, Arg210, Try212, 
Asn214, Arg216, Gly217, Glu218, Gly219, Lys220, Leu224, Arg234, Thr236, Asn239, Ala265, 
Asn266, Gln268, and Phe269.  Likewise, on RPA70B perturbations were observed on Asp314, 
Thr330, Ile332, Val334, Val341, Ala365, Gly362, Gly380, Arg382, Lys394, Val393, and 
Phe415 (Figure 3.5).  Importantly, the residues identified are in the same vicinities of the domain 
suggesting that the site of interaction is specific. 
 Interestingly, in the RPA70AB crystal structure, loop L45 from the 70A domain curves 
around the DNA and is held in place by Phe238 and Phe269 aromatic ring stacking between the 
DNA bases forming a closed conformation upon binding DNA [45].  
15
N-relaxation and 
chemical shift perturbation experiments performed on 70A also showed that binding-induced 
changes in the 70A structure involved residues in L45 loop [5].  These NMR chemical shift 
perturbation experiments show that Phe269 is perturbed when RPA70A alone, but not in the 
context of RPA70AB and Phe238 is not perturbed.  Other residues indirectly affected by ssDNA 
binding in the crystal structure include Trp212-S223 residues in the Leu12 loop and the β2 
strand, Ser234-Asn239 in the β 3 strand, and Asn266-Glu277 in the Leu45 loop.  Some of these 
residues are in the same vicinity as the perturbations observed in RPA70AB by addition of the 
peptide.  Interestingly, polar residues Arg210, Arg216, Arg234 and Lys263 shown to be essential 
for high affinity to ssDNA [120] were perturbed on RPA70A.  However, only Arg234 and 
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Figure 3.5.  
15
N-
1
H HSQC spectra RPA70A and RPA70B upon titration of RPA32N-D8. 
15N-RPA70A
15X RPA32ND8
15N-RPA70B
15X RPA32ND8
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were perturbed on RPA70AB. An RPA mutant which contained Arg234A and Lys263A 
mutations, in addition to Glu277A mutation, was shown to have a reduced ssDNA binding 
activity measured to less than 1% of the WT [120].  However, this mutant can support normal 
replication activity.  Consistent with this, fluorescence measurements of full-length WT and 
mitotic phosphorylated RPA forms showed that both proteins have similar ssDNA binding 
activities [60].  On the contrary, a mutant with Arg210A, Try212A, Arg216A, Arg234A and 
Lys263A mutations, in addition to Glu277A, has reduced ssDNA binding activity and reduced 
replication activity while mutations on aromatic residues alone activate the cell cycle checkpoint 
control [120].  In addition, Try212, Arg216, Arg234 and Lys263 and other surrounding residues 
are involved in direct interaction with Rad51 N-terminus domain, and although this interaction 
had no effect on RPA70A ssDNA binding activity, it was important for RPA displacement from 
ssDNA. On RPA70B, perturbations on Val334, Arg344, Arg382 and Ser384 confirm the 
observations from MS footprinting analysis.  Thus, as previously observed with RPA70N, 
residues surrounding the ssDNA binding region of RPA70AB participate in the interaction with 
the RPA32N-D8 peptide.  Residues corresponding to the observed interaction have been mapped 
to the RPA70AB structure (Figure 3.6). 
 The interaction of RPA32N-D8 with the RPA70N subunit was confirmed by reciprocal 
titration experiments on 
15
N-
1
H enriched RPA32N-D8 peptide.  In addition, titration of unlabeled 
RPA70NAB resulted in a different set of perturbations that also confirms the additional 
interactions observed in the presence of RPA70AB.  Near complete resonance assignments of 
RPA32N-D8 allowed for partial identification of the peptide residues involved in the interactions 
(Figure 3.7).  Residues 10, 15-26, 28, 33 and 43 were perturbed in the interaction.  These include 
six of the nine glycines (10, 15, 16, 18, 19, and 18), two alanines (17, 43), three of the nine 
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 Figure 3.6.   Contact points in RPA70A and RPA70B interaction with RPA32N-D8 are 
highlighted in red.   Most interacting residues belong to RPA70A.  
 
aspartic acids (21, 23 and 29) and Tyr20.  However, due to large overlap in the RPA32N-D8 
spectrum, Asp8, Asp11, Asp12, Asp13, and Asp29 have not been assigned and it is possible that 
these residues also experienced chemical shift perturbations.  Residues Met1, Trp2, Ala31, 
Ser39, Arg40 and Ala41 were not perturbed. 
 Given that three RPA70 domains interact with the pseudo-phosphorylated peptide, and 
given its size and innate flexibility, we propose that in order for hyperphosphorylated RPA32N 
to interact with all RPA70 domains, it must do so transiently by switching between one domain 
and another.  Therefore, we asked if any of these interactions was more favorable than the others 
in order to understand if some interactions are more biologically relevant. To answer this 
question, I used NMR reverse titration experiments.  Data was acquired for two samples of 
known concentrations, one containing 
15
N-labeled protein alone (RPA70N, RPA70A, RPA70B, 
or RPA70AB) and the other containing the matching 
15
N-labeled protein saturated with a 15 fold 
excess of the RPA32N-D8.  Spectra of these two samples were collected as initial and final 
points of titration.  Then 50 μl from each sample were swapped to collect intervening titration 
points, and the process was repeated various times resulting in 8-10 titration points.  Specific 
resonance assignments were transferred to each spectrum, and the chemical shift change for 
90 ° 90 °
RPA70B RPA70A RPA70A RPA70A RPA70B
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Figure 3.7.  RPA32N-D8 backbone specific assignments. 
 
every residue at each titration point was calculated.  Although the number of titration points 
collected was not very large, it was possible to estimate a range of Kd values.   An unassigned 
residue for RPA70N at 128, 7.712 ppm; residues Glu218 and Gly219 from RPA70A; and 
Arg344 and Gly362 from RPA70B were used to estimate the binding affinity using xcrvfit 
software. The calculated binding affinities were 4.1 + 1.0 x 10
-4
 M, 3.9 + 0.8 x 10
-4
 M, 7.8 + 1.2 
x 10
-4
 M, 4.6 + 1.0 x 10
-4
 M, and 7.9 + 2.0 x 10
-4
 M, respectively.  Notably, the observed 
chemical shift perturbations were smaller in the context of RPA70AB.  Thus, affinities obtained 
for RPA70A and RPA70B residues Glu218, Gly219, Arg344 and Gly362 in the isolated domains 
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where compared to those obtained in RPA70AB. The calculated binding affinities were 7.5 + 1.0 
x 10
-4
 M, 8.8 + 1.1 x 10
-4
 M, 1.3 + 0.8 x 10
-3
 M, and 1.8 + 1.0 x 10
-3
 M, respectively.   
 To help envision how this is happening, electrostatic potential maps were calculated to 
evaluate the charge contributions to the interactions of RPA32N-D8 with RPA70 domains 
(Figure 3.8).  A larger electrostatic potential for RPA70A may explain the greater number of 
residues, compared to RPA70B, that interact with RPA32N-D8. 
 
 
RPA32N-D8 interaction is specific to the RPA70 subunit  
Weak interactions can sometimes be observed as a product of non-specific binding.  This can 
occur depending on the electrostatic properties of two proteins and as a consequence of high 
concentrations such as during saturation of one constituent in an NMR titration experiment.  
However, specific weak interactions are important for biological function.  These result in 
transient associations that are often coupled to regulation of a protein’s biological function or 
activity [121].  In order to demonstrate that phosphorylated RPA32N intersunit interactions are  
Figure 3.8. Electrostatic Potential maps.  Electrostatic maps for RPA70NAB domains is shown.  
The blue area represents basic surfaces, while the red area represents acidic surfaces. 
 
RPA70N RPA70B RPA70A
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specific to the RPA70 subunit and do not result from macromolecular bumping due to high 
concentration of ligand, we asked if any other domains in RPA might interact with RPA32N-D8 
peptide.  Chemical shift perturbations assays were performed by titration of unlabeled 
RPA32/14, RPA32D/14 and RPA32C to 18 μM 15N-RPA32N-D8 up to a 20-fold excess molar 
ratio in buffer containing 10 mM HEPES at pH 6.8, 50 mM NaCl and 5 mM BME.  These 
experiments showed that there are no chemical shift differences in the 
15
N-RPA32N-D8 
spectrum upon addition of the proteins, and demonstrated that the pseudo-phosphorylated 
peptide does not interact with these domains (Figure 3.9).  Likewise, chemical shift perturbation 
experiments with the RPA32Nwt peptide demonstrated that the unphosphosphorylated RPA32N 
also does not interact with RPA32D/14 or RPA32C.  The same experiment was performed on 
15
N-RPA70C/32D/14, a construct which contains the C-terminal domain of the RPA70 subunit.  
Although chemical shift perturbations were not detected upon addition of RPA32N-D8, only a 
threefold excess was achieved in this experiment.  Thus, we cannot rule out the possibility that 
RPA70C may also have a weak interaction and is involved.   
 
Production and Characterization of RPAD9 phospho-mimic mutant 
 Previous work in our laboratory involving RPA heterotrimer has utilized a pET15b RPA 
construct that produces a 6X-His tagged full-length protein.  However, the yield and stability of 
the protein are not very good with this construct.  In addition, the purity of the sample after a 
series of purification steps is still not great.  Although we have managed to perform experiments 
with this construct, we felt that introducing mutations could result in the same or even lower 
yield and/or potentially unstable protein.  To optimize this construct, we decided it was best to  
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Figure 3.9.   
15
N-
1
H HSQC titrations.  
15
N-enriched RPA32N-D8 (blue) was saturated with 20X 
excess RPA32D/14 (red, a) or RPA32C (red, b).  No chemical shift perturbations are indicative 
of a lack of interaction. 
   
use a different vector system.  An optimized version of the full-length wild-type RPA 
heterotrimer and several versions of full-length phosphorylated RPA were produced through 
collaboration with Dr. Miaw-Sheue Tsai in the Structural Cell Biology of DNA Repair Machines 
(SDBR) group at Laurence Berkley National Laboratory.   
 The already existing pET15b RPA tri-cistronic construct was engineered by the 
laboratory of Dr. Alexey Bochkarev.   The open reading frame for the RPA70 subunit was placed 
in front followed by RPA14 and RPA32, respectively.  The protein contains a cleavable 6X-His 
tag on RPA70 and a non-cleavable RPA14 His tag.  According to previous characterization of a 
pET11b RPA construct developed by the laboratory Dr. Mark Wold, RPA70 is the lowest copy 
a b
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transcript, and was positioned in front to promote a higher yield of trimer [122].  Thus, the same 
subunit order was adopted.  The RPA constructs were designed with cleavable 10X-His-tags at 
the N-terminus of RPA70 (H3C protease specific) and RPA14 (TEV protease specific) subunits 
and cloned into a 10X-His pBG106 vector.  Pseudo-hypophosphorylated RPA (Ser23,29 → Asp) 
and pseudo-hyperphosphorylated RPA (Ser4,8,11,12,13,23,29,33→Asp and Thr21→Asp) 
mutant proteins were produced based on our knowledge of residues that become phosphorylated 
in response to cell cycle events and DNA damage [68, 123] (Figure 3.10). 
To examine the structural dynamics of RPA-D9 and investigate the impact of 
hyperphosphorylation on RPA conformation, purification conditions were optimized and 
preliminary SAXS data for RPAwt and RPA-D9 were acquired.  As demonstrated in Chapter II, 
monodispersity of samples is critical because small amounts of aggregation or contaminants 
would distort the scattering leading to misinterpretation of the results.  Therefore, multiple 
purification steps were implemented to achieve the purity of the RPA samples, albeit at the cost 
of reducing the final yield.   
 
 
Figure 3.10.  Design of pBG106 RPA constructs.  Full-length RPAwt and a pseudo 
phosphorylated mutant were constructed in a pBG106 vector.  RPA70 and RPA14 subunits 
contain 10X-His tags at their N-terminus cleavable with H3C and TEV proteases, respectively.  
RPA32N sequence is shown bellow.  Phosphorylatable residues mutated to aspartic acid are 
highlighted in red. 
1  4   8     11,12,13                  21   23  29 33   
MWNSGFESYGSSSYGGAGGYTQSPGGFGSPAPSQAEKKSRARAQHI
*****
RPA70 RPA14 RPA32
T7 prom.
RBS RBS
T7 term.
H10 RBS
BamHI EcoRI SalI NotI
H10
3C TEV
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 For RPAwt, the data were truncated and scattering at high angles was absent in the 
preliminary experiments due to the small amount of protein available.   RPA protein preparations 
are notoriously unstable, and it is possible that partial degradation of the sample may have 
occurred in the interim between preparation and data collection, resulting in insufficient amounts 
for SAXS.  In contrast, scattering data for the RPA-D9 mutant were successfully recorded.    
Purification of RPA-D9 mutant yielded greater amounts of protein.  SAXS data was acquired for 
the RPA-D9 sample at 14 μM (1.5 mg/ml) (Figure 3.11).  An Rg of 64.7 Å was derived directly 
from the data based on the Guinier analysis (Figure 3.12).  The Kratky analysis shows the curve 
plateaus at high I(q)*q
2
 when q > 0.15.  This pattern is characteristic for the presence of some 
disordered regions, consistent with the presence of RPA32N and the long inter-domain linkers.   
The P(r) function shows multiple peaks, reflecting the scattering of the different domains.  The 
curve extends to a Dmax of 220 Å, which is consistent with the available structural information 
for the seven globular domains and the intrinsic flexibility of RPA.  These data obtained for full-
length RPA mutant demonstrate the feasibility of the SAXS approach for analyzing the effect of 
phosphorylation on the structural dynamics of RPA. 
 
Figure 3.11.  SAXS data acquired for RPA-D9:  (a) Scattering curve; (b) Kratky analysis; (c) 
P(r) function  
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Figure 3.12.  Scattering data for RPA-D9 does not show signs of aggregation.  SDS-PAGE of 
the sample is shown in the left panel.  Guinier Analysis from the SAXS data is shown at right.   
 
 
Discussion 
 RPA mediates interactions with ssDNA and target proteins to coordinate the progression 
of DNA processing events.  Hypophosphorylation of RPA by cdk/cyclin dependent kinases takes 
place as part of a regulatory mechanism during normal replication activity [56, 124].  In the 
presence of DNA damage, RPA becomes hyperphosphorylated by the PI3K family of kinases.  
This is thought to make RPA “repair competent” by means of recruitment of repair factors to 
sites of DNA damage [57, 58, 68, 76-79, 82].   Evidence supporting this hypothesis is very 
extensive.  PI3K family of kinases are activated in response to DNA damage [74, 80], and the 
fact that RPA is a target of these kinases is the first clue to understanding that it is involved in 
repair activities.  It has been shown that hyperphosphorylated RPA is inactive in replication, and 
arrest of replication activity correlates with the loss of hypophosphorylated forms of RPA [58].  
Cell studies have also shown that hyperphosphorylated RPA is localized to sites of DNA damage 
upon UV exposure [68, 123].  Moreover, RPA association with proteins involved in replication 
is weakened upon hyperphosphorylation [60].  In contrast, association with proteins involved in 
recombinatorial repair is move avid upon hyperphosphorylation [69].    
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 Despite the existence of atomic resolution information for its seven structured domains, 
the overall disposition of RPA domains and hence the structural details of its mechanism of 
action are unknown.  Thus changes that occur in RPA structure upon hyperphosphorylation 
cannot easily be addressed.  However, two studies have contributed insight into potential 
hyperphosphorylation-specific structural effects.  
15
N-
1
H HSQC NMR titrations of the isolated 
15
N-RPA70N domain with a synthetic RPA32N phosphomimetic mutant peptide showed 
evidence for a weak interaction occurring via the basic cleft of RPA70N [44].  Further evidence 
for intersubunit interactions was demonstrated in intact hyperphosphorylated RPA through 
potential binding of RPA32N to RPA70B.  However, there was no indication for RPA70N 
interaction [119].  It has been hypothesized that hyperphosphorylation driven intersubunit 
interactions may affect RPA-DNA and RPA-protein interactions [3, 44, 119].   
 The studies presented here demonstrate that RPA32N hyperphosphorylation-dependent 
intersubunit interactions occur via the RPA70N, A, and B domains and utilize SAXS to examine 
the structural effect of hyperphosphorylation on RPA.  Although preliminary data is available for 
RPAD9, several further studies are required.  In order to fully interpret the effect of 
hyperphosphorylation on RPA, detailed comparisons to the wild-type protein are required.  
These studies will be challenging because comparisons will be limited to low resolution SAXS 
parameters such as Dmax and Rg values in this highly flexible molecule.  To complete the 
analysis, our laboratory is pursuing an approach of building up models of smaller RPA 
fragments.  These models can be used to construct a composite model for the intact RPA 
heterotrimer.   This approach would allow us to build a comprehensive picture of the time-
varying architecture of free RPA.  Once these studies are complete, we will have the proper 
platform for further studies to addresses the effect of hyperphosphorylation on full-length RPA.  
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Re-acquisition of RPA-D9 SAXS data will be necessary as the experiment needs to be performed 
in parallel with RPAwt due the great sensitivity of SAXS to the solution conditions and the 
variance in the intensity of the beam line.   In addition to hyperphosphorylation, delineation of 
the scattering contributions of the RPA domains will also facilitate studies of remodeling as RPA 
binds ssDNA and other DNA processing partners.   With this goal in mind, I had previously 
optimized purification conditions and collected SAXS data for all RPA fragments available in 
our laboratory in a collaboration with Drs. Kevin L. Weis and Ragavan Aravinda at Oak Ridge 
National Laboratories (ORNL), with whom we collected data at a local source and at the 
Advanced Photon Source (APS) at the Argone National Laboratory.  However, all SAXS data 
shown in this thesis were acquired through collaboration with Susan Tsutakawa in the laboratory 
of John Tainer at the SYBILS beam line at Berkeley National Laboratory.  The implications of 
our findings will be further discussed in Chapter IV. 
 
Experimental Procedures 
Cloning.  
 Primers were designed to clone RPA32N 1-35 and 1-46 residues.  The first 35 residues of 
RPA32 span the functional domain, and the next 10 residues (36 to 46) span the linker to the rest 
of the subunit.  For the RPA32Nwt peptide, RPA32F forward primer (5’-
CGCGGATCCGCGATGTGGAACAGTGGA-3’) contains a BamH1 restriction site 
(underlined) and ATG start codon. Reverse primers RPA32R35 (5’-
CCGGAATTCCGGTTAGGCTTGAGAAGG-3’) and RPA32R46 (5’-
CCGGAATTCCGGCTAAATGGTCTGCTGGGCTCG-3’) contain an EcoR1 restriction site 
(underlined) and either TTA or TAA stop codon.  The same restriction sites were used for 
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construction of RPA32N phosphomutant peptides.  RPA32FS4/8D forward primer (5’-
GGATCCGCGATGTGGAACGATGGATTCGAAGAC-3’), and either RPA32RS33D (5’-
TGATTTCTTTTCGGCTTGATCAGGTGCTGGA-3’), or RPA32R46 reverse primer were used.  
Plasmids were amplified using a 20 μl polymerase chain (PCR) reaction using New England 
Biolabs (NEB) Vent polymerase.  Full-length wild-type or mutant RPA heterotrimer were used 
as templates. The amplified DNA fragments were separated in 2% agarose gels, and extracted 
using a Quiagen gel extraction kit.  Each time insert and vector, either Invitrogen pET15b (6X-
His), or in-house pBG102 (6X-His-Sumo tag) and pLm102 (6X-His-MBP tag), were digested 
overnight at 37 °C with NEB BamH1 and EcoR1 enzymes.  The next day the reactions were run 
on a gel and the digested plasmids isolated and eluted in 50 μl TE buffer.  The ligation reaction 
was set up using the quick T4 ligation system from NEB, and the construct was transformed into 
XL1-Blue cells and plated onto ampicillin or kanamycin plates.  DNA sequencing confirmed that 
the constructs contained the targeted sequences.  
 Construction of plasmids for the full-length RPA proteins was in collaboration with Dr. 
Miaw-Sheue Tsai at Laurence Berkley National Laboratories.  To create an N-10X-His H3C 
tagged RPA70, RPA70-1F forward primer (5’-
GCGGGATCCATGGTCGGCCAACTGAGCGAGGGGGCC-3’) contained a BamH1 restriction 
site, and RPA70-616R reverse primer (5’-
CCGGAATTCTCACATCAATGCACTTCTCCTGATGC-3’) contained the Eco R1 restriction 
site. To create an N-10X-His-TEV tagged RPA14 subunit, a RPA14-1F forward primer(5’-
CCGGAATTCTTTTTGTTTAACTTTAAGAAGGAGATATACCATGCACCATCACCATCA
CCATCACCATCACCATCACCATAGCAGCGAGAATCTTTATTTTCAGGGCATGGTGGA
CATGATGGACTTGCCCAGG-3’) contained an EcoR1 site, RBS site, 10X-His, linker and 
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TEV sequences prior to start codon.  The RPA14-121R reverse primer (5’ 
AGCGGTCGACTCAATCATGTTGCACAATCCC-3’) contained a Sal1 restriction site.  To 
create an untagged RPA32 subunit, primer RPA32-1F (5’- 
AGCGGTCGACTTTTTGTTTAACTTTAAGAAGGAGATATACCATGTGGAACAGTGGAT
TCGAAAGC-3’) contained a Sal1 restriction site and a RPA32-270R reverse primer (5’- 
ATAAGAAGCGGCCGCTTATTCTGCATCTGTGGATTTAAAATGGT) contained a NotI 
restriction site. 
 
Protein Expression  
 pBG102 RPA32Nwt, pBG102 RPA32N-D8, pET15b RPA32D/14, pET15b RPA32C, 
pET15b RPA70C/32D/14 plasmids were transformed into Novagen BL21 (DE3) cells.  pET28b 
RPA70AB, pBG100 RPA70NAB and pET15b RPA70N1-120 (obtained from the laboratory of 
Cheryl Arrowsmith) were expressed in LB using Novagen Rosetta (DE3) cells.  Unlabeled 
proteins were prepared using LB medium containing kanamycin (pBG102 RPA32Nwt, pBG102 
RPA32N-D8, pET28b RPA70AB, pBG100 RPA70NAB) or carbenicillin (pET15b RPA32D/14, 
pET15b RPA32C, pET15b RPA70C/32D/14, and pET15b RPA70N1-120) at 37 °C.   Uniform 
15
N- and 
15
N-
13
C- labeled proteins were produced similarly, except for using M9 media enriched 
with 
15
NH4Cl and 1 ml 10% yeast extract.  Proteins were purified using Sigma nickel-
nitrilotriacetic acid resin (NiNTA) using an elution gradient from 10 to 300 mM imidazole, and 
size exclusion chromatography (SEC) using superdex 75 or superdex 200 resin.    
 pBG106QC7 RPA-D9 mutant was transformed into Novagen Rosetta (DE3) cells.  The 
cells were plated after only 30 minutes of shaking rather than 1 hour.  A 150 mL LB-kanamycin 
pre-culture was grown for 3 hours at 37 °C.   Six 500 mL rich-autoinduction-kanamycin cultures 
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prepared in wide 2L glass flasks were inoculated with 10 ml of the 150 mL pre-culture at 37 °C 
overnight for a total of 13 hours.  The pelleted cells were immediately processed for Nickel 
purification using a modified buffer to improve stability and purity of the sample.  Buffers 
contained 30 mM Tris at pH 8.0, 1 M NaCl, 10 mM BME, 10 μM ZnCl2, 5 mM MgCl2, 30 → 
300 mM imidazole, 0.25% NP-40 and 5% glycerol.  Cleavage of the tags was only partially 
successful in spite of using increasing amounts of H3C and TEV proteases, therefore the tags 
were not cleaved in the final protein preparation. 
 
Protein Purification  
 RPA32N peptides were purified in buffer containing 10 mM HEPES at pH 7.0, 50 mM 
NaCl, 10% glycerol.  The His tag was cleaved during dialysis with H3C protease in 10 mM 
HEPES at pH 7.0, 100 mM NaCl, and 10% glycerol. A second NiNTA purification step was 
used to remove the His tag.  Peptides were concentrated using a 3 kDa molecular weight cut-off 
concentrator in their existing buffer prior to exchanging into the NMR buffer.  1X peptide 
solution was mixed with 4X NMR buffer and concentrated down to 1 ml, and the process 
repeated twice again.  After the third exchange, the concentration was re-checked and adjusted 
using NMR buffer.   
 The RPA70A and RPA70B proteins were purified using NiNTA in 10 mM HEPES at pH 
7.5, 500 mM NaCl and 5 mM BME.  The His tag was not removed from these proteins. 
15
N-
RPA70AB protein was purified using NiNTA in 10 mM HEPES at pH 7.5, 500 mM NaCl, 5 mM 
BME, and 10% glycerol using an elution gradient from 20 to 300 mM imidazole. The His tag 
was cleaved with TEV protease during dialysis overnight in 10 mM HEPES at pH 7.5, 200 mM 
NaCl, 5 mM BME, 200 mM L-arginine, and 10% glycerol.  A Superdex 75 column was used as a 
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last step of purification.  Similarly, 
15
N-RPA70NAB samples were purified in 30 mM MES at 
pH 6.5, 500 mM NaCl, 10 mM BME, and 5 mM MgCl2.  The His tag was cleaved using H3C 
protease during dialysis overnight and separated with a Superdex 200 column in 30 mM MES at 
pH 6.5, 200 mM NaCl, 10 mM BME, 10% glycerol, and 5 mM MgCl2.  Prior to NMR 
experiments, RPA70A, RPA70B, and RPA70AB were dialyzed overnight at 4 °C in NMR buffer 
containing 20 mM Tris at pH 7.2, 2 mM DTT, 50 mM KCl, and 10 mM MgCl2.  RPA70NAB 
buffer contained 10 mM HEPES at pH 6.8, 50 mM NaCl and 5 mM BME.  All proteins were 
concentrated using a 10 kDa molecular weight cut-off concentrator the day of the experiment. 
 RPA32C, RPA32/14 and RPA32D/14 proteins were purified using NiNTA in buffer 
containing 50 mM Tris at pH 8.0, 500 mM NaCl and 5 mM BME.  Prior to experiments, proteins 
were buffer exchanged 3 times into NMR buffer containing 10 mM HEPES, pH 6.8, 50 mM 
NaCl, and 5 mM BME buffer.   
 RPA70C/32D/14 was purified using NiNTA in buffer containing 10 mM HEPES at pH 
7.5, 500 mM NaCl, 5 mM BME, 10% glycerol and 10 uM ZnCL2.  Prior to experiments, 
RPA70C/32D/14 was buffer-exchanged three times into 10 mM HEPES at pH 7.5, 125 mM 
NaCl and 2 mM BME. 
 RPA-D9 mutant was purified using NiNTA in buffer containing 30 mM Tris at pH 8.0, 
1M NaCl, 10 mM BME, 10 uM ZnCl2, 5 mM MgCl2, 30 → 300 mM imidazole, 0.25% NP-40 
and 5 % glycerol.  The sample was desalted into Source Q buffer A using a 54mL desalting 
column at 4 °C.  Source Q buffers contained 50 mM Tris at pH 8.7, 100 mM L-arginine, 10% 
glycerol, 10 uM ZnCl2, 5 mM MgCl2 and 5 mM DTT.    The same buffer was used for S200 gel 
filtration. 
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DNA sequencing 
   Sequencing was performed at the Vanderbilt University DNA sequencing core facility.  
DH5α or XL1bue cells expressing RPA32N peptides were grown overnight in LB medium, 
which contained the appropriate antibiotic.   DNA was isolated using a Quiagen mini-prep kit.  
Sequencing was performed using a T7 promoter primer. 
 
MALDI Mass spectrometry 
 Mass spectrometry analysis was performed at the Mass Spectrometry Research Center at 
Vanderbilt University using a MALDI Voyager Elite instrument (Applied Biosystems).  A 
matrix was prepared that contained 10 mg of synapinic acid, 500 ul 0.1 % TFA and 500 ul 
acetonitrile.  Calibration standards included insulin (5.7 kDa), cytochrome C (12 kDa) and 
albumin (66 kDa).  Analysis of RPA32Nmt peptide was done using 256 scans with a 2500 laser. 
 
NMR Chemical Shift Perturbation Assays 
 All NMR experiments were performed on 500 or 600 MHz Bruker spectrometers with a 
cryoprobe and operating at 25 °C or 15 °C. Two-dimensional 
15
N-
1
H-HSQC spectra were 
acquired on uniformly 
15
N-enriched samples of RPA32Nwt, RPA32N-D8, RPA70N, RPA70A, 
RPA70B, and RPA70AB in 90% H2O/10% D2O, and in the presence of unlabeled proteins 
titrated to assess interactions.  Buffers used for NMR titration experiments were as follows:  20 
mM Tris-d11 HCl at pH 7.2 containing 50 mM KCl, 10 mM MgCl2 and 2 mM DTT.   
 All NMR data were processed using TOPSPIN (Bruker Biospin Ltd.) and analyzed using 
Sparky (University of California, San Francisco).  Kd values were determined using XWINNMR 
V 3.1 (Bruker). 
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NMR Resonance Assignments 
 In order to map the residues in RPA32N-D8 that interact with RPA70NAB, it is 
necessary to obtain backbone assignments.   Since RPA32N-D8 is a small peptide, an initial 
attempt was made to determine sequential backbone assignments using 2D homonuclear NOESY 
and TOCSY spectra [99, 103].  An observation of the NOE from the NOESY spectrum provides 
information about proton-proton interactions through space, while the TOCSY spectrum 
provides information of the specific spin pattern of residues.  Analysis of these spectra together 
is sometimes enough to perform sequential assignments for small peptides.  However, the severe 
chemical shift overlap due to absence of regular secondary structure precluded the completion of 
assignments using the 2D data sets [99].  Therefore, we turned to standard triple resonance NMR 
experiments using 
13
C, 
15
N-enriched RPA32N-D8 peptide.   The following experiments were 
acquired:  
15
N-
1
H HSQC, 
13
C-
1
H HSQC, HNCA, HN(CA)CB, CBCA(CO)NH, and HNCO. 
 Although the 3D data helped to determine assignments, I was able to complete only 50% of 
sequence specific assignments due to the severe overlap of cross peaks.   
 
Small Angle X-ray Scattering 
 SAXS data of RPAD9 construct was collected at the SIBYLS 12.3.1 beam line at the 
Advanced Light Source, Lawrence Berkeley National Laboratory. Scattering measurements were 
performed on 20 μL samples at 15 °C using a Hamilton robot for loading samples from a 96-well 
plate into a helium-purged sample chamber. Protein samples were purified on a 24 mL Superdex 
200 SEC column as a final step of purification and kept at 4 °C until data collection. Data were 
collected on both the original gel filtration fraction and samples concentrated 2−8-fold from 
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individual fractions. Fractions prior to the void volume and concentrator eluates were used for 
buffer subtraction. 
 The experiments were collected using an X-ray beam from a multilayer monochromator 
of 12 keV covering the following momentum transfer range: 0.012 Å
−1
< q < 0.317 Å
−1
, where 
(q = 4π sin Θ/λ, where 2Θ is the scattering angle). Sequential exposures (0.5, 1, 0.5, 5, 0.5, and 
10 s) were taken, and data were monitored for radiation-dependent aggregation.  All SAXS data 
were collected using the MarCCD 165 detector in fast frame transfer mode and reduced via 
normalization to the incident beam intensity. Buffer scattering was subtracted from protein 
scattering. This was followed by azimuthally averaging to obtain the intensity I(q) 
versus q scattering plot visualized by xmgrace. The data were analyzed using PRIMUS (Primary 
Analysis & Manipulations with Small Angle Scattering Data) version 3.0 from ATSAS 
2.0 [115], from which Guinier, Kratky, and P(r) plots were generated. 
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CHAPTER IV 
DISCUSSION AND FUTURE DIRECTIONS 
 
Influence of RPA70N on RPA ssDNA binding activity 
 Studies presented in Chapter II investigate the putative ssDNA binding activity of 
RPA70N and the conformational freedom of RPA70NAB.  RPA70N was found to be structurally 
independent of RPA70AB alone and in the DNA-bound state.  SAXS-derived Dmax and Rg 
changes in RPA70NAB upon binding of 14mer or 8mer ssDNA were similar, and the magnitude 
of these changes was similar to those observed for RPA70AB alone.  Molecular dynamics 
simulations were used to model the substantial inter-domain flexibility in RPA70AB and 
RPA70NAB.   These results support a model in which RPA70N is freely available and therefore 
able to act as a protein recruitment module.  This model is supported by studies showing 
RPA70N is not essential for DNA replication [120] and that RPA70N binds multiple proteins 
involved in DNA repair activities [32, 39, 41, 125].  
 
The role of flexibly linked domains in RPA function 
 Binding of ssDNA forms part of the larger cellular goal of conservation of the DNA.  A 
dynamic and continuous assembly and disassembly of DNA processing proteins, like RPA, is 
necessary throughout every cell cycle.  RPA assembles into a heterotrimeric DNA binding core 
with peripheral flexible domains appended to the core (Figure 4.1).  Flexible linkers joining RPA 
domains provide a basis for its dynamic architecture,  and  allow RPA remodeling as a function 
of ssDNA and partner binding proteins [4].  Inter-domain flexibility also plays an important role 
in the recruitment of proteins by RPA.   
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 Figure 4.1.  RPA is composed of globular domains combined with disordered regions.  The 
DNA binding core is composed of RPA70ABC/32D.  Peripheral domains are appended to the 
core through flexible linkers shown as dotted lines.  The disordered RPA32N domain is also 
shown as a dotted line.  Ribbon diagrams were generated from PDB entries (1EWI, 1JMC, 
1L1O, 1DPU). 
 
 
 RPA binds proteins involved in all DNA metabolic pathways including replication, 
recombination, repair and cell cycle checkpoint control.  RPA protein interactions are specific.  
General features include significant electrostatic contributions to binding and common 
interaction sites, which suggest competition between proteins for binding to RPA.  A hand-off 
mechanism has been proposed to explain how RPA exchanges protein partners and orchestrates 
the dynamic assembly of DNA processes [26].   RPA70N and RPA32C protein interaction 
domains are appended to the heterotrimer through long linkers [4].  The RPA70 N-A linker is 
32N
70N
70A
70B
32D
32C
70C
14
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especially very long, spanning 60 residues.  The RPA32 D-C linker is 30 residues long.  The 
flexible attachment of the RPA DNA and protein binding domains in RPA70NAB was directly 
characterized in Chapter II.  We proposed that the flexibility of the connecting linkers increases 
the inter-domain dynamics and also allows RPA70N and RPA32C to reach out away from the 
DNA binding core to recruit partner proteins for effective orchestration of DNA replication and 
repair.  
 Similar flexible attachments joining protein and DNA binding domains were recently 
discovered for DNA-PK and polynucleotide kinase [109, 110]. In fact, inter-domain structural 
flexibility as experimentally defined here has been proposed to be essential to allow efficient 
protein handoffs and interface exchanges for FEN1-PCNA [111] and BRCA2-Rad51[112]. RPA 
binding protein partners, such as the Mre11−Rad50−Nbs1 complex, have similar ordered and 
flexible domains, as shown by Nbs1 SAXS and crystal structures [113]. Such dynamic character 
may be a hallmark for scaffold proteins such as RPA.  However, the usefulness of the various 
linker lengths has never been assessed.  It can be predicted that shortening of the linkers may 
have an effect on RPA protein-protein interactions.  It would be interesting to investigate the 
minimum number of residues necessary to mediate functions. RPA70N for instance, interacts 
with a number of proteins involved in the ATR checkpoint response.  It is conceivable that a 
mutant with a shorter RPA70N-A linker may not effectively recruit these checkpoint proteins 
and cause in a defective checkpoint response.  Alternatively, proteins may be recruited but 
complexes may not form properly to mediate function.  This would indicate that the length of the 
linker allows strategic placement of proteins by sustaining appropriate intermolecular distances 
required for complex formation.  I believe RPA32C functions similarly, mediating interactions 
with proteins involved in recombinatorial repair and nucleotide excision repair.    
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 The effectiveness of the linkers can also be assessed through deletion of the linked 
peripheral domains in the heterotrimer, in the presence of the same peripheral domains in 
isolation.  In addition to loss of direct binding, such experiments could enable assessment of the 
effect of dilution of the high local concentration of the peripheral domains and increased entropy 
in the recruitment of protein binding partners.  This information could provide a useful way to 
design RPA mutants that may potentially discriminate specific protein interactions to assay for 
the effect of specific interactions in replication initiation or in response to DNA damage.   
 Protein interactions with RPA70AB present a different scenario.  These major ssDNA 
binding domains are presumably bound to ssDNA when protein interactions take place.  At least 
one interaction that overlaps with the RPA70A ssDNA binding site has been identified in 
recombinatorial repair:  Rad51 N-terminus interacts with RPA70A residues that participate in 
ssDNA binding [25].  Competition with ssDNA for RPA70A site was found to be important in 
RPA displacement assays  leading to RPA disassembly and Rad51 filament formation in the 
initiation of homologous recombination.  Similarly, the SV40 large T-antigen (Tag) helicase 
domain interaction with the RPA70 A-B linker is important in loading  and disassembly of RPA 
[20].   Interestingly, preliminary studies suggest multiple contact points exist between RPA and 
Rad51 as has been shown for Tag [20, 21].  However, even for Tag, these networks have yet to 
be completely characterized.   Such studies would refine our understanding of RPA displacement 
in replication, initiation of homologous recombination, damage response and repair.    
 
RPA structural dynamics 
 Our understanding of the role of RPA structural dynamics of RPA in ssDNA binding is 
incomplete.  Biochemical studies found that RPA binds ssDNA in multiple modes, which 
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correlate with different structural and functional states of the protein. The initial ssDNA binding 
mode involving RPA70AB (binding of 8 nt) has been characterized by crystallography and NMR 
[7, 45].  We have yet to understand how RPA70C (binding of 12-23 nt, [9, 126]) and RPA32D 
(binding of 27-30 nt, [9, 126]) engage in ssDNA binding.  The crystal structure of 
RPA70C/32D/14 leads to the hypothesis that RPA70C may align in tandem with RPA70B, and 
ssDNA may wrap around the trimer core to reach the basic cleft of RPA32D [14].  Intrinsic 
fluorescence spectroscopy analysis of RPA using various lengths of ssDNA derived a model for 
ssDNA-RPA complex [15].  Fluorescent probes on the ssDNA identified that RPA70C makes 
contact with nucleotide 16 and RPA32D with nucleotide 24, when intact RPA is fully engaged.  
This information was put into context with the assumption that the RPA70C/32D/14 crystal 
structure model exists in solution. With this caveat, a model of a kinked ssDNA bound to RPA 
has been proposed [15].  However, RPA remodeling via domain reorganization must be studied 
to better understand the implications of ssDNA binding.  Our understanding of how initiation of 
replication and protein recruitment takes place is dependent upon this critical aspect of RPA 
function.   Therefore it would be important to characterize the structural basis for these last two 
RPA ssDNA binding modes.   
 NMR relaxation analysis is currently in used in the Chazin laboratory as an approach to 
understand the motions that dominate ssDNA binding to RPA70AB.  This approach will be 
extended to the RPA DNA binding core (RPA70ABC/32D/14).  Neutron scattering contrast 
variation experiments in combination with SAXS will extract basic scattering functions for the 
RPA-DBC and ssDNA for three ssDNA substrates of eight, twenty and thirty bases long.  
Observations of changes in vector distribution or P(r) functions, Rg and Dmax will be translated 
into structural models for RPA at every transition step of ssDNA binding.  These studies will 
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also provide a guide for analysis of scattering data for the full length RPA heterotrimer, 
including the hyperphosphorylation mutant as discussed in Chapter III.    
 Significant architectural heterogeneity much like that reported for RPA70NAB in 
Chapter II, is expected in full length RPA (Figure 4.2).   In fact, preliminary SAXS data on a 
mimic of hyperphosphorylated RPA (RPAD9), provides evidence of RPA’s intrinsic flexibility.  
NMR spectra collected on the full length RPA heterotrimer show that in the free and ssDNA 
bound forms, RPA70N and RPA32C domains tumble independently of the core in solution.  
Even RPA70A and RPA70B domains remain flexible enough to tumble independently from the 
rest of the heterotrimer when engaged in binding ssDNA [4].  Therefore, remodeling upon      
 
Figure 4.2.  Structural dynamics of RPA.  The flexible linkers in RPA allow formation of many 
different architectures.  Subunits of RPA are color coded with RPA70 in red, RPA32 in yellow 
and RPA14 in blue. 
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ssDNA binding may directly affect protein-protein interactions with proteins involved in the 
initiation of replication.  However, it should be noted that many critical RPA interactions 
presumably occur after RPA is loaded onto ssDNA.   
 
Role of protein dynamics in DNA processing 
 The key role of dynamics in facilitating the organization and progression of large 
multiprotein machines is increasingly recognized, particularly for DNA replication and repair 
machinery that requires precise coordination to efficiently preserve genome integrity.  The 
role of dynamics in facilitating recruitment, organization, and exchange of DNA processing 
factors has been characterized in several model systems, most notably in a recent study of 
homotetrameric E. coli SSB diffusion dynamics along ssDNA [114].  In that study, SSB 
diffusion was shown to be critical for resolving DNA secondary structures to enable RecA 
filament formation.  Unlike the modular, multidomain RPA, the homotetrameric single-domain 
SSB does not utilize preexisting structural dynamics to facilitate organizing strands of ssDNA 
for DNA processing.  Instead, the compact, globular SSB homotetramer is encircled by the 
ssDNA and is thought to “roll” along the template via a consecutive unwrapping and wrapping 
of ssDNA. Thus, while the structural organization of these two SSB systems remains 
fundamentally different, dynamic motion would appear to be integral aspects of both. 
Specifically, the nature of the structural dynamics of linked, ordered, and flexible RPA domains 
as identified here appears to be critical to the accommodation of the large-scale complex 
conformational changes proposed to regulate RPA-related functions, while preserving the 
integrity of DNA and protein partner interactions for maintaining genetic fidelity. 
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RPA32N interactions within RPA 
 RPA32N harbors all RPA phosphorylation sites shown so far to be functionally relevant 
[68].  NMR and CD spectra demonstrated that this region is unstructured.  In addition, I showed 
that a pseudo-hyperphosphorylated RPA32N peptide can bind to RPA70NAB, and that this  
 
 
Figure 4.3.  Phosphorylated RPA32N peptide.  A surface representation of the 
hypophosphorylated (a) and  hyperphosphorylated (b) RPA32N peptide is shown in an arbitrary 
extended conformation.  Residues that are phosphorylated are highlighted in red. 
 
interaction is mediated through residues that are normally involved in protein-protein 
interactions (RPA70N and RPA70A) and ssDNA binding (RPA70AB). These interactions are 
consistent with a role of RPA32N in regulating RPA function via phosphorylation.   
a
b
21 23
MWNSGFESYGSSSYGGAGGYTQSPGGFGSPAPSQAEKKSRARAQHI
4          8       11,12,13                  21  23               29       33       
MWNSGFESYGSSSYGGAGGYTQSPGGFGSPAPSQAEKKSRARAQHI
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 In the cell, the number of phosphorylated residues at any given time varies, with 
increased phosphorylation of RPA32N in response to DNA damage.  Phosphorylation of 
multiple residues dramatically changes the electrostatic properties of RPA32N (Figure 4.3) and 
this correlates with observations that phosphorylation of RPA32N affects RPA function.  It is 
well established that phosphorylation activates or deactivates many proteins causing or 
preventing the progression of cellular processes.  Proteins that become activated via 
phosphorylation may interact with new partners.  So far, interactions with RPA32N have only 
been studied within RPA. Therefore, other than inter-subunit interactions, no specific protein-
protein interactions have been identified involving this domain.  One obvious expectation is 
interaction with kinases that phosphorylate RPA32N.  However, it would be logical to 
investigate if proteins involved in DNA damage response also interact specifically with the 
hyperphosphorylated RPA32N. 
 
The role of hyperphosphorylation in the function of RPA 
 Phosphorylation of RPA32N perturbs RPA interactions with replication proteins, and 
hyperphosphorylated RPA is not active in replication [60, 68].  It can be expected that inter-
subunit interactions form part of a phosphorylation dependent regulation of RPA function.  The 
standing hypothesis in the literature is that hyperphosphorylation causes a global conformational 
change in RPA70AB, affecting its ssDNA binding activity, and that this is regulated by RPA70N 
preferred binding to the hyperphosphorylated RPA32N [3].  This hypothesis was built on NMR 
evidence for a specific intersubunit interaction between the RPA70N and an RPA32N 
phosphomimetic peptide [44], and MALDI MS fingerprinting evidence of conformational 
changes involving RPA70B in DNA PK in vitro phosphorylated RPA [119].  However, the 
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interaction between RPA70N and RPA32N phosphomimic peptide is very weak, in the high μM 
range.  Also, the observation that a large percentage of the RPA70 subunit in the in vitro 
phosphorylated RPA was partially proteolyzed prompted the suggestion that RPA70N was 
cleaved in the MS fingerprinting studies.  
 Intrinsic fluorescence studies in this protein showed decreased interactions with short 
ssDNA [119].   This information was correlated with analysis of a pseudo-phosphorylated RPA 
mutant harboring a deletion of the RPA70N that showed reduced binding to short ssDNA and no 
detectable DNA helix destabilization activity [3].  An idea was set forth that changes in 
RPA70AB only occur when RPA70N cannot exert a protective function. 
 
Hyperphosphorylation and ssDNA binding activity 
 The data presented here shows that RPA32N intersubunit interactions occur mainly via 
basic residues in the clefts of RPA70NAB OB-fold domains.  RPA32N-D8 interacting residues 
in RPA70AB participate in ssDNA binding, although estimates of the affinity indicate binding in 
the 100-1000 μM regime.  In contrast, RPA70AB binds ssDNA with Kd ~100 nM [7]. Thus, an 
effect due to direct competition between a hyperphosphorylated RPA32N and ssDNA for 
RPA70AB binding site seems unlikely. This is consistent with evidence in the literature 
suggesting that hyperphosphorylation does not affect RPA ssDNA binding:  surface plasmon 
resonance experiments indicated that hyperphosphorylation does not change RPA affinity for 
ssDNA [44].  Similarly, fluorescence studies demonstrate that hypophosphorylated RPA has a 
similar affinity for ssDNA as the wild type protein [60].  Thus, the level of phosporylation is not 
expected to affect ssDNA binding.  I also note that hyperphosphorylation of RPA occurs in its 
ssDNA bound state.  The persistence of foci at sites of DNA damage suggests the 
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hyperphosphorylated RPA remains bound to ssDNA [68].  This is consistent with ssDNA 
binding activity of RPA being comparable to that of wild type RPA. 
 Although RPA32N does not appear to directly disrupt RPA binding to ssDNA, studies 
investigating direct competition studies between an RPA70NAB-ssDNA complex and 
hyperphosphorylated RPA32N would confirm this prediction.  However, one caveat is such 
studies examine RPA in isolation, while DNA processes occur in presence of many different 
factors that could be important in modulating the effect of hyperphosphorylation of RPA on 
binding ssDNA.  Importantly, the observed weak inter-subunit interactions I observed by NMR 
may be relevant for RPA function in the cellular context.  The high local concentration of 
hyperphosphorylated RPA32N resulting from its linkage to the heterotrimer should increase the 
frequency of interactions and could therefore affect the overall structural dynamics of RPA.   
  
The effect of hyperphosphorylation on RPA:  The compaction model 
 Since hyperphosphorylation does not mediate direct changes in DNA binding activity, the 
question of how does RPA32N hyperphosphorylation influences RPA function  remains obscure.  
Based on the physical interaction observed between RPA32N and RPA70NAB, we favor a 
model of RPA compaction upon hyperphosphorylation (Figure 4.4).  In this model, RPA70N is 
on average closer to RPA70AB than in the non-phosphorylated protein.  Such a scheme does not 
alter the ssDNA mechanism because RPA70N is not involved in ssDNA binding.  It does 
however provide the advantage of close localization of these domains, which may facilitate the 
exchange of protein interactions.   
 We also considered the possibility of a more extended RPA model in which RPA70N is 
extended away from RPA70AB.  In this model, intersubunit and intermolecular protein-protein 
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interactions can be shared with the neighboring RPA molecule (Figure 4.5).  Such a model has 
been proposed to explain the formation of ATR-ATRIP complex with Rad9 and TOPBP1, each 
of which have been shown to bind to RPA70N [41].  Insight into the validity of this model is 
available from analysis of wt and RPA hyperphosphorylation mutants by SEC.  Estimates of the 
Stokes Radius of RPA species from SEC shows that the stokes radius of an RPA32N mutant that 
contained aspartic acid mutations to mimic hyperphosphorylation  is very similar to the wild type 
RPA [3].  If the model in Figure 4.5 were accurate, one would anticipate RPA molecules would 
exhibit at least some tendency to aggregate, which would be reflected in a significant increase in 
Stokes Radius.  Although the SEC observations do not support the extended model, they do not 
conclusively refute it.  
 Electron microscopy characterization of RPA ssDNA bound forms identified RPA 
complexes aligned along the ssDNA in either a contracted or an extended form that was 
dependent on ssDNA length [118].  Importantly, phosphorylation of RPA with DNA PK 
appeared to stimulate formation of extended RPA-30mer complexes.  However, imaging of RPA  
 
 
 
Figure 4.4.   Model for compaction upon hyperphosphorylation.  RPA70 domains N, A and B 
are shown in red.  Highlighted stars represent hyperphosphorylation on RPA32N.  
Hyperphosphorylation causes a general compaction of RPA that might affect the overall protein 
structural dynamics and protein interaction network.  ssDNA and potential interacting proteins 
have been left out of this illustration for simplicity. 
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Figure 4.5.  Hyperphosphorylation model of extended RPA.  RPA70 domains N, A and B are 
shown in red.  Highlighted stars represent hyperphosphorylation on RPA32N.  This alternative 
extended model implicates interaction between neighboring RPA molecules. ssDNA and 
potential interacting proteins have been left out of this illustration for simplicity. 
 
 
in these electro micrographs is dependent on the density of ssDNA.  This suggests that only 
density from RPA ssDNA binding core domains is highlighted, and the density of the flexibly 
linked domains may not contribute to their observations.  This means that phosphorylation of 
RPA takes place on the full assembled (30 nt bound) protein.  The results from this study reflect 
changes in population of  binding modes and is a good indication that RPA can exist in more 
than one conformation.  However, there is no evidence that RPA oligomerizes [118].  In 
summary, although both models are consistent with phosphorylation not affecting ssDNA 
binding and are able to satisfy all interactions involving RPA32N, the global compaction model 
is better supported by the available data and is therefore more likely.      
 Given the lack of data, it will be necessary to gain a better understanding of 
hyperphosphorylation and the role of intersubunit interactions by directly characterizing the 
overall changes in the intact RPA heterotrimer. One potential approach for this is SAXS, since 
the distribution of interatomic distances and maximum dimensions of the wild-type versus 
hyperphosphorylated RPA proteins can be compared.  As shown in Chapter III, a full-length 
hyperphosphorylation mutant constructed in collaboration with SBDR Molecular Biology Core 
70N70A
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at Lawrence Berkley National Laboratory provided promising preliminary SAXS data.  Thus, 
there are excellent prospects for directly testing the validity of the compaction and 
oligomerization models for the effect of hyperphosphorylation on RPA.   
 
The compaction model and RPA hyperphosphorylation in replication, recombinatorial 
repair, and checkpoint signaling 
 The functional switch associated with hyperphosphorylation of RPA may result from 
change in the ability of RPA to unload and reload on ssDNA.  The rearrangement and 
compaction resulting from RPA32N hyperphosphorylation would prevent RPA from being re-
loaded on ssDNA for replication by simply preventing or weakening selected RPA protein 
interactions with RPA-loading proteins.  However, I note that there is no evidence that RPA 
loading by the SV40 large Tag helicase is disrupted by RPA32N hyperphosphorylation.   
 Interestingly, RPA32C interacts with an acidic surface on Tag-OBD, analogous to the 
acidic hyperphosphorylated RPA32N.  However, RPA32C does not bind RPA32N-D8.   It would 
be interesting to test if hyperphosphorylated RPA32N could bind Tag OBD.  If this were the 
case, the hyperphosphorylated peptide could compete with RPA32C for Tag OBD, affecting the 
stimulation of primer synthesis perhaps by interfering with Tag interaction with Pol α.  This 
would be consistent with studies showing that phosphorylation of RPA affects its interaction 
with DNA pol α [60].  Tag OBD binds origin DNA with greater affinity than RPA32C.  
Although hyperphosphorylation of RPA32N mimics ssDNA, it is unlikely that Tag OBD-origin 
DNA interaction could be impaired by hyperphosphorylation since it occurs after initiation of 
replication.    These speculations clearly require further studies.   
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 In humans, the MCM2-7/CDC45/GINS complex is the active helicase in DNA 
replication.  Whether MCM2-7 loads RPA analogous to what has been shown with Tag helicase 
and if this activity may be impaired by hyperphosphorylation of RPA is unknown.  Interestingly, 
it was found that depletion of CDC45, a helicase cofactor, suppresses RPA hyperphosphorylation 
and foci formation.  The same is true in CHK1 depleted cells exposed to HU or thymidine, 
ultimately suppressing apoptosis [89].  One explanation could be that RPA loading on ssDNA 
was precluded, therefore hyperphosphorylation was impaired.  In Xenopus egg extracts, 
functional uncoupling of helicase and polymerase activities in response to aphidicolin is 
dependent on MCM helicase [127].  This uncoupling causes the helicase to continue to unwind 
DNA that results in increased generation of ssDNA and RPA foci formation, leading to 
amplification of CHK1 signaling.  However, uncoupling was abrogated when MCM7 or CDC45 
were inhibited [128].  Moreover, inactivation of MCM helicase and DNA pol α activity 
abrogates CHK1 signaling [128] .  Together, this evidence also indicates that helicase complexes 
may be important for RPA loading, which is a pre-requisite for hyperphosphorylation.  However, 
experiments directly addressing this question must be performed before any conclusions can be 
drawn.   
 Although the ssDNA binding capacity of RPA70AB may not be significantly affected by 
hyperphosphorylation, RPA binding to ssDNA may be indirectly affected.  One idea is that 
hyperphosphorylation could indirectly promote the removal of RPA from ssDNA.  A simple 
explanation of how this may happen is that hyperphosphorylation promotes interactions with 
recombination and repair proteins.  For example, RPA is displaced from exposed ssDNA ends by 
Rad51, with help of Rad52.  Rad51 N-terminal domain interaction with RPA70A occurs at the 
same site for RPA32N and ssDNA binding.  In fact, it has been shown that ssDNA and Rad51N 
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compete for RPA70A binding site.    Although Rad51N affinity for ssDNA is weak and it cannot 
displace ssDNA, mutagenesis analysis showed the importance of this contact for efficient Rad51 
mediated displacement of RPA [25].  Likewise, weak RPA intersubunit interactions in 
hyperphosphorylation may indeed have a subtle effect in RPA activity.  And it remains to be 
investigated why Rad51 and Rad52 efficiency of interaction with RPA is enhanced in the 
presence of hyperphosphorylated RPA32N [129].  Rad51 and Rad52 are DNA binding proteins 
and hyperphosphorylation of RPA32N mimics ssDNA.  It is possible that hyperphosphorylated 
RPA32N mediates an additional interaction point that provides an advantage in protein 
recruitment, or a contribution to a synergistic binding effect through multiple weak interactions.  
These properties may contribute to the displacement of RPA and Rad51 filament formation.  In 
order to explore this possibility, it would be necessary to perform direct protein-protein 
interaction studies and displacement assays in the presence of hyperphosphorylated RPA.   
 Most recently, our laboratory has found that Dss1, a 70 residue protein involved in 
recombinatorial repair activities through modulation of BRCA2 also interacts simultaneously 
with the RPA70N, RPA70A and RPA70B domains (Dr. Sivaraja Vaithiyalingham unpublished 
results).   Because Dss1 is so small, simultaneous interaction of all three RPA domains with 
DSS1 must result in compaction of RPA, suggesting that an RPA compaction mechanism as 
proposed here may also be utilized in other contexts of RPA function.     
 It has been shown that RPA recruits checkpoint proteins to sites of DNA damage [41].  
Although hyperphosphorylation of RPA has not been considered in the recruitment of checkpoint 
proteins under DNA damage conditions, a vast number of research articles have shown that 
treatment of cells with UV or IR causes the hyperphosphorylation of RPA, which is the 
predominant form found at DNA damage sites.  Hyperphosphorylated RPA32N specifically 
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recruits checkpoint proteins in close proximity to the damaged DNA region.  In support of this 
idea, RPA70N domain has been shown to bind to various proteins involved in cell cycle control 
and DNA damage response, such as ATRIP, Rad9, MRE11 and p53 [32, 39-41].  It has been 
shown that RPA bound to ssDNA is required for high levels of ATRIP to accumulate at sites of 
DNA damage [39].  ATRIP and ATR both bind RPA:  ATR can bind to RPA32 independent 
from ATRIP and ATRIP can bind RPA70N independent of ATR.  After irradiation of HCT116 
cells with 50 J/m
2
 of UV, or HeLa cells with 10 Gy of IR, the ATR-ATRIP complex colocalizes 
with RPA-covered ssDNA [90].  Thus, persistent localization of hyperphosphorylated RPA at 
DNA damage sites would result in accumulation of the ATR-ATRIP complex and other repair 
factors. One interesting observation is that ATR/ATRIP phosphorylation of CHK1 is dependent 
on RPA [90].  A reduction of CHK1 phosphorylation was observed upon HU or UV treatment in 
HeLa cells, or UV treatment in U2OS cells transfected with siRNA to RPA70 (absence of 
RPA70 subunit precludes the assembly of the RPA heterotrimer).  A greater reduction was 
observed at higher doses of UV, which would normally correlate with higher levels of 
hyperphosphorylation of RPA.  Because the kinases respond to DNA damage, it is possible that 
hyperphosphorylation of RPA during DNA damage may contribute to efficient checkpoint 
complex formation promoting CHK1 phosphorylation and proficient DNA damage signaling.    
 
Significance 
 The focus of the work presented in this thesis is the influence of peripheral domains 
RPA32N and RPA70N on the organization and DNA binding activity of Replication Protein A.  
This research contributes observations on RPA domain dynamics and intersubunit interactions.  
Consideration of these findings must be taken into account in defining the mechanism of RPA in 
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protein recruitment and response to DNA damage.  Although we and others have gained many 
insights from studying the isolated RPA protein and domain fragments, the processing of ssDNA 
occurs through the combined effect of multiple full-length proteins in complexes. Protein 
structural dynamics are influenced by the interaction with their partners and actions leading to 
function will not be completely understood until the complete machinery is characterized. 
Developing the capability to work with intact proteins and their complexes will be most 
important in discovering the nuances of DNA processing events.   
 RPA is a critical component for the progression of DNA processing events essential for 
eukaryotic cell survival and reproduction.   Elucidating the actions of RPA in the protection of 
ssDNA and orchestration of dynamic multi-protein machines is critical for understanding how 
DNA processing is coordinated in the cell.   My research has expanded the knowledge of the 
dynamic RPA architecture and explored the effects of phosphorylation of RPA32.  Protection of 
the ssDNA intermediate by RPA is fundamental to all DNA processing events, and the 
phosphorylation of RPA plays a central role in the switch of replication activity to repair when 
DNA damage occurs.  The work presented here contributes to basic understanding of how RPA 
functions and its ability to integrate the many DNA transactions essential for life.   
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